Delaware
|
| |
7371
|
| |
88-2789488
|
(State or Other Jurisdiction of Incorporation or Organization)
|
| |
(Primary Standard Industrial Classification Code Number)
|
| |
(I.R.S. Employer
Identification Number)
|
Large accelerated filer
|
| |
☐
|
| |
|
| |
|
| |
Accelerated filer
|
| |
☐
|
Non-accelerated filer
|
| |
☐
|
| |
(Do not check if a smaller reporting company)
|
| |
|
| |
Smaller reporting company
|
| |
☒
|
|
| |
|
| |
|
| |
|
| |
Emerging growth company
|
| |
☒
|
•
|
trends in the cannabis industry and SpringBig’s market size, including with respect to the potential total addressable market
in the industry;
|
•
|
SpringBig’s growth prospects;
|
•
|
new product and service offerings SpringBig may introduce in the future;
|
•
|
the price of SpringBig’s securities, including volatility resulting from changes in the competitive and highly regulated
industry in which SpringBig operates and plans to operate, variations in performance across competitors, changes in laws and regulations affecting SpringBig’s business and changes in the combined capital structure;
|
•
|
the ability to implement business plans, forecasts, and other expectations as well as identify and realize additional
opportunities; and
|
•
|
other risks and uncertainties indicated from time to time in filings made with the SEC.
|
•
|
SpringBig’s platform offers retailers text message marketing, which allows clients to send promotions to existing
customers. This text messaging platform offers a variety of features, including multiple customer segmentations, which automatically groups customers into segments based on their preferences and purchase behavior. Retailers also have
access to the “autoconnects” feature, which allows them to easily leverage customer data and send messages directly to consumers based on certain actions and also includes functionality to help clients identify opportunities to send
text messages. SpringBig also provides an e-signature app, designed to accommodate proper ‘double opt-in’ procedure, through both implied and expressed consent to facilitate compliance with the TCPA, FCC, and Canadian CRTC.
|
•
|
The consumer application (or wallet) offered by SpringBig allows customers to access and check their points, redeem
rewards, and view upcoming offers. The wallet fully integrates with cannabis e-commerce providers, allowing customers to place orders directly from their wallet. Retailers can customize this application with a distinct icon, name,
layout, and color scheme, thus allowing for brand consistency and a higher-quality and frictionless customer experience.
|
•
|
Retailers can use the SpringBig platform to compile marketing campaigns based on consumer profiles and preferences. Once a
campaign launches, retailers are able to analyze in-depth data in order to measure campaign success. Enterprise Resource Planning (or ERP)-level customer data management and analysis also allow retailers to organize their sales funnel
and provide a personalized, targeted approach to marketing campaigns.
|
•
|
SpringBig’s platform integrates with many point of sale (“POS”) systems used in the cannabis industry, allowing retailers
to automatically collect additional data on consumers.
|
•
|
SpringBig has a brand marketing platform that offers a direct-to-consumer marketing automation platform specifically for
cannabis brands. This direct-to-consumer marketing engine allows brands to target and measure the complete transaction cycle from initial engagement through point of sale.
|
•
|
SpringBig provides brands with the opportunity to provide content that, in turn, SpringBig’s retail clients can utilize in
their targeted consumer marketing campaigns. This provides the brand with access to the consumer and that can be leveraged through the brand and retailer cooperating in a promotional campaign on the SpringBig platform. The SpringBig
platform can be used by brands to increase their brand awareness, expand retail partnerships, and acquire and retain new customers. The SpringBig brands platform also provides brand clients with access to detailed reports regarding
campaign attribution metrics.
|
•
|
It is not possible to predict the actual number of Common Shares, if any, we will sell under the Purchase Agreement to
Cantor, or the actual gross proceeds resulting from those sales.
|
•
|
Investors who buy Common Shares from the Holder at different times will likely pay different prices.
|
•
|
We may use proceeds from sales of our Common Shares made pursuant to the Purchase Agreement in ways with which you may not
agree or in ways which may not yield a significant return.
|
•
|
We are engaged in multiple transactions and offerings of Company securities. Future resales and/or issuances of Common
Shares, including pursuant to this prospectus may cause the market price of our shares to drop significantly.
|
•
|
We have a relatively short operating history in a rapidly evolving industry, which makes it difficult to evaluate our
future prospects and may increase the risk that we will not be successful. As our costs increase, we may not be able to generate sufficient revenue to maintain profitability in the future. We also have a history of losses and may not
achieve profitability in the future.
|
•
|
If we do not successfully develop and deploy new software, platform features or services to address the needs of our
clients, our business, financial condition, and results of operations could suffer.
|
•
|
If we fail to retain our existing clients and consumers or to acquire new clients and consumers in a cost-effective manner,
our revenue may decrease and our business may be harmed.
|
•
|
If we fail to expand effectively into new markets, our revenue and business will be adversely affected.
|
•
|
Federal law enforcement may deem our clients to be in violation of U.S. federal law, and, in particular the CSA. A change
in U.S. federal policy on cannabis enforcement and strict enforcement of federal cannabis laws against our clients would undermine our business model and materially affect our business and operations.
|
•
|
Some of our clients currently and in the future may not be in compliance with licensing and related requirements under
applicable laws and regulations and we do not, and cannot, ensure that our client will conduct their business activities in a manner in compliance in all respects with regulations and requirements.
|
•
|
Our business is dependent on U.S. state laws and regulations and Canadian federal and provincial laws and regulations
pertaining to the cannabis industry, as well as continued market acceptance of cannabis by consumers.
|
•
|
Our business is highly dependent upon our brand recognition and reputation, and any erosion or degradation of our brand
recognition or reputation would likely adversely affect our business and operating results.
|
•
|
We currently face intense competition in marketing and advertising services available to our clients, and we expect
competition to further intensify as the cannabis industry continues to evolve.
|
•
|
If we fail to manage our growth effectively, our brand, business and operating results could be harmed. The growth of our
business depends on our ability to accurately predict consumer trends, successfully offer new services, improve existing services and expand into new markets.
|
•
|
If we are unable to recruit, train, retain and motivate key personnel, we may not achieve our business objectives.
|
•
|
If our current marketing model is not effective in attracting new clients, we may need to employ higher-cost sales and
marketing methods to attract and retain clients, which could adversely affect our profitability.
|
•
|
We may be unable to scale and adapt our existing technology and network infrastructure in a timely or effective manner to
ensure that our platform is accessible, which would harm our reputation, business and operating results.
|
•
|
Interruptions to, or perceived errors, failures, or bugs in our platform and other cyber-events affecting our platform or
our systems could adversely affect our operating results and growth prospects.
|
•
|
The impact of global, regional or local economic and market conditions or catastrophic events, including health crises, may
adversely affect our business, operating results and financial condition.
|
•
|
Fluctuations in our quarterly and annual operating results may adversely affect our business and prospects.
|
•
|
Investors are cautioned not to rely on outdated financial projections.
|
•
|
We may improve our products and solutions in ways that forego short-term gains.
|
•
|
We are subject to a variety of standards, governmental laws, regulations and other legal obligations and any actual or
perceived failure to comply with such obligations could harm our business. Changes to such standards, laws, regulations and other obligations may have material adverse effect on our business, cash flow, financial condition or
operating results.
|
•
|
Future investments in our growth strategy, including acquisitions, could disrupt our business and adversely affect our
operating results, financial condition and cash flows.
|
•
|
The terms of the agreements governing our funding may restrict our operations.
|
•
|
We may need to raise additional capital, which may not be available on favorable terms, if at all, causing dilution to our
stockholders, restricting our operations or adversely affecting our ability to operate our business. We may be unable to obtain additional financing to fund our operations or growth and we are limited in our ability to obtain
additional financing under the terms of our Notes and Investor Warrants.
|
•
|
We have obligations secured by a security interest in substantially all of our assets; in the event of a default, the
noteholders could foreclose on, liquidate and/or out take possession of our assets.
|
•
|
We may be subject to potential adverse tax consequences both domestically and in foreign jurisdictions and we may not be
able to utilize our net operating loss and tax credit carryforwards.
|
•
|
Changes in accounting standards or other factors could negatively impact our future effective tax rate.
|
•
|
Certain taxing authorities may successfully assert that SpringBig should have collected or that in the future SpringBig
should collect sales and use or similar taxes for certain services which could adversely affect our results of operations.
|
•
|
Our business and our clients are subject to a variety of U.S. and foreign laws regarding financial transactions related to
cannabis. Cannabis remains illegal under federal law, and therefore, strict enforcement of federal laws regarding cannabis would likely result in our inability to execute our business plan.
|
•
|
We are dependent on our banking relations, and we may have difficulty accessing or consistently maintaining banking or
other financial services due to our connection with the cannabis industry. We also may have a difficult time obtaining the various insurances that are desired to operate our business, which may expose us to additional risk and
financial liability.
|
•
|
We may have difficulty using bankruptcy courts or enforcing our commercial agreements due to our involvement in the
regulated cannabis industry.
|
•
|
The conduct of third parties may jeopardize our business.
|
•
|
A failure to comply with laws and regulations regarding our use of telemarketing, including the TCPA, could increase our
operating costs and materially and adversely impact our business, financial condition, results of operations, and prospects.
|
•
|
We may continue to be subject to constraints on marketing our products.
|
•
|
Cannabis businesses may be subject to civil asset forfeiture.
|
•
|
Due to our involvement in the cannabis industry, we may have a difficult time obtaining the various insurances that are
desired to operate our business, which may expose us to additional risk and financial liability.
|
•
|
We may in the future be, subject to disputes and assertions by third parties with respect to alleged violations of
intellectual property rights. These disputes could be costly to defend and could harm our business and operating results.
|
•
|
Some of our solutions contain open source software, which may pose particular risks to our proprietary software and
solutions.
|
•
|
The success of our business heavily depends on our ability to protect and enforce our intellectual property rights.
|
•
|
The price of our securities may be volatile.
|
•
|
We do not intend to pay cash dividends for the foreseeable future.
|
•
|
We may be subject to securities litigation, which is expensive and could divert management attention.
|
•
|
The issuance of our Common Shares in connection with the Notes and Warrants Purchase Agreement could cause substantial
dilution, which could materially affect the trading price of our Common Shares.
|
•
|
A significant portion of our total outstanding shares may be sold into the market in the near future, including the shares
being registered for resale pursuant to this prospectus. This could cause the market price of our Common Shares to drop significantly, even if our business is doing well.
|
•
|
If securities or industry analysts do not publish or cease publishing research or reports about us, our business, or our
market, or if they change their recommendations regarding our common stock adversely, the price and trading volume of our common stock could decline.
|
•
|
We may amend the terms of the warrants in a manner that may be adverse to holders with the approval by the holders of at
least 65% of then outstanding public warrants. As a result, the exercise price of your warrants could be increased, the exercise period could be shortened and the number of Common Stock purchasable upon exercise of a warrant could be
decreased, all without your approval.
|
•
|
We are an emerging growth company within the meaning of the Securities Act, and if we take advantage of certain exemptions
from disclosure requirements available to emerging growth companies, this could make our securities less attractive to investors and may make it more difficult to compare our performance with other public companies.
|
•
|
We have and will continue to incur increased costs as a result of operating as a public company and our management has and
will continue to devote a substantial amount of time to new compliance initiatives.
|
•
|
Our failure to timely and effectively implement controls and procedures required by Section 404(a) of the Sarbanes-Oxley
Act could have a material adverse effect on our business.
|
•
|
Anti-takeover provisions in our certificate of incorporation and bylaws and under Delaware law could delay or prevent a
change in control, limit the price investors may be willing to pay in the future for our Common Shares and could entrench management.
|
•
|
Our largest shareholders and certain members of our management own a significant percentage of our Common Shares and are
able to exert significant control over matters subject to shareholder approval.
|
•
|
Future sales and issuances of our Common Shares, including pursuant to our equity incentive and other compensatory plans,
will result in additional dilution of the percentage ownership of our shareholders and could cause our share price to fall. The issuance of additional shares in connection with the Company’s outstanding Notes and Investor Warrants
could cause substantial dilution, which could materially affect the trading price of our shares.
|
•
|
the Commitment Fee Shares, which are the 877,193 Common Shares that we have agreed to issue to Cantor in consideration of
its irrevocable commitment to purchase Common Shares at our election under the Purchase Agreement; and
|
•
|
up to 4,178,331 Common Shares consisting of Common Shares that we may elect, in our sole discretion, to issue and sell to
Cantor, from time to time from and after the Commencement Date (as defined below) under the Purchase Agreement.
|
•
|
sales and marketing, including continued investment in our current marketing efforts and future marketing initiatives;
|
•
|
successfully compete with existing and future providers of other forms of marketing and customer engagement;
|
•
|
managing complex, disparate and rapidly evolving regulatory regimes imposed by U.S. and Canadian federal, state and
provincial, local and other non-U.S. governments around the world applicable to cannabis and cannabis-related businesses;
|
•
|
executing our growth strategy;
|
•
|
hire, integrate and retain talented sales and other personnel;
|
•
|
expansion domestically and internationally in an effort to increase our client usage, client base, retail locations we serve,
and our sales to our clients;
|
•
|
development of new products and services, and increased investment in the ongoing development of our existing products and
services;
|
•
|
continuing to invest in scaling our business, particularly around client success and engineering;
|
•
|
avoiding interruptions or disruptions in our platform or services; and
|
•
|
general administration, including a significant increase in legal and accounting expenses related to public company
compliance, continued compliance with various regulations applicable to cannabis industry businesses and other work arising from the growth and maturity of our company.
|
•
|
managing complex, disparate and rapidly evolving regulatory regimes imposed by U.S. and Canadian federal, state and
provincial, local and other non-U.S. governments around the world applicable to cannabis and cannabis-related businesses;
|
•
|
adapting to rapidly evolving trends in the cannabis industry and the way consumers and cannabis industry businesses interact
with technology;
|
•
|
maintaining and increasing our base of clients;
|
•
|
continuing to preserve and build our brand while upgrading our existing offerings;
|
•
|
successfully competing with existing and future participants in the cannabis marketing and advertisement market and related
services;
|
•
|
successfully attracting, hiring, and retaining qualified personnel to manage operations;
|
•
|
adapting to changes in the cannabis industry if the sale of cannabis expands significantly beyond a regulated model, and
commodification of the cannabis industry;
|
•
|
successfully implementing and executing our business and marketing strategies;
|
•
|
successfully expanding our business into new and existing cannabis markets; and
|
•
|
successfully executing on our growth strategies.
|
•
|
the efficacy of our marketing efforts;
|
•
|
our ability to maintain a high-quality, innovative, and error- and bug-free platform and similarly high quality client
service;
|
•
|
our ability to maintain high satisfaction among clients (and our clients’ consumers);
|
•
|
the quality and perceived value of our platforms and services;
|
•
|
successfully implementing and developing new features and revenue streams;
|
•
|
our ability to obtain, maintain and enforce trademarks and other indicia of origin that are valuable to our brand;
|
•
|
our ability to successfully differentiate our platforms and services from competitors’ offerings;
|
•
|
our ability to integrate with POS systems;
|
•
|
our ability to provide our clients with accurate and actionable insights from the consumer data and feedback collected
through our platform;
|
•
|
our compliance with laws and regulations;
|
•
|
our ability to address any environmental, social, and governance expectations of our various stakeholders;
|
•
|
our ability to provide client support; and
|
•
|
any actual or perceived data breach or data loss, or misuse or perceived misuse of our platforms.
|
•
|
actions of competitors or other third parties;
|
•
|
consumers’ experiences with retailers or brands using our platform;
|
•
|
public perception of cannabis and cannabis-related businesses;
|
•
|
positive or negative publicity, including with respect to events or activities attributed to us, our employees, partners or
others associated with any of these parties;
|
•
|
interruptions, delays or attacks on our platforms; and
|
•
|
litigation or regulatory developments.
|
•
|
our ability to attract new clients and retain existing clients;
|
•
|
our ability to accurately forecast revenue and appropriately plan our expenses;
|
•
|
the effects of increased competition on our business;
|
•
|
our ability to successfully expand in existing markets and successfully enter new markets;
|
•
|
the impact of global, regional or economic conditions;
|
•
|
the ability of licensed cannabis markets to successfully grow and outcompete illegal cannabis markets;
|
•
|
our ability to protect our intellectual property;
|
•
|
our ability to maintain and effectively manage an adequate rate of growth;
|
•
|
our ability to maintain and increase traffic to our platform;
|
•
|
costs associated with defending claims, including intellectual property infringement claims and related judgments or
settlements;
|
•
|
changes in governmental or other regulation affecting our business;
|
•
|
interruptions in platform availability and any related impact on our business, reputation or brand;
|
•
|
the attraction and retention of qualified personnel;
|
•
|
the effects of natural or man-made catastrophic events and/or health crises (including COVID-19); and
|
•
|
the effectiveness of our internal controls.
|
•
|
political, social, and economic instability;
|
•
|
risks related to the legal and regulatory environment in foreign jurisdictions, including with respect to privacy and data
protection, and unexpected changes in laws, regulatory requirements, and enforcement;
|
•
|
fluctuations in currency exchange rates;
|
•
|
higher levels of credit risk and payment fraud;
|
•
|
complying with tax requirements of multiple jurisdictions;
|
•
|
enhanced difficulties of integrating any foreign acquisitions;
|
•
|
the ability to present our content effectively in foreign languages;
|
•
|
complying with a variety of foreign laws, including certain employment laws requiring national collective bargaining
agreements that set minimum salaries, benefits, working conditions, and termination requirements;
|
•
|
reduced protection for intellectual property rights in some countries;
|
•
|
difficulties in staffing and managing global operations and the increased travel, infrastructure, and compliance costs
associated with multiple foreign locations;
|
•
|
regulations that might add difficulties in repatriating cash earned outside the United States and otherwise preventing us
from freely moving cash;
|
•
|
import and export restrictions and changes in trade regulation;
|
•
|
complying with statutory equity requirements; and
|
•
|
complying with the U.S. Foreign Corrupt Practices Act of 1977, as amended and the Corruption of Public Officials Act
(Canada), and similar laws in other jurisdictions.
|
•
|
an acquisition may negatively affect our operating results, financial condition or cash flows because it may require us to
incur charges or assume substantial debt or other liabilities, may cause adverse tax consequences or unfavorable accounting treatment, may expose us to claims and disputes by third parties, including intellectual property claims and
disputes, or may not generate sufficient financial return to offset additional costs and expenses related to the acquisition;
|
•
|
we may encounter difficulties or unforeseen expenditures in integrating the business, technologies, products, personnel or
operations of any company that we acquire, particularly if key personnel of the acquired company decide not to work for us, and potentially across different cultures and languages in the event of a foreign acquisition;
|
•
|
the acquired business may not perform at levels and on the timelines anticipated by our management and/or we may not be able
to achieve expected synergies;
|
•
|
an acquisition may disrupt our ongoing business, divert resources, increase our expenses and distract our management;
|
•
|
an acquisition may result in a delay or reduction of sales for both us and the company we acquire due to uncertainty about
continuity and effectiveness of products or support from either company;
|
•
|
we may encounter difficulties in, or may be unable to, successfully sell any acquired products or services;
|
•
|
an acquisition may involve the entry into geographic or business markets in which we have little or no prior experience or
where competitors have stronger market positions;
|
•
|
potential strain on our financial and managerial controls and reporting systems and procedures;
|
•
|
potential known and unknown liabilities associated with an acquired company;
|
•
|
if we incur debt to fund such acquisitions, such debt may subject us to material restrictions on our ability to conduct our
business as well as financial maintenance covenants;
|
•
|
the risk of impairment charges related to potential write-downs of acquired assets or goodwill in future acquisitions;
|
•
|
to the extent that we issue a significant amount of equity or convertible debt securities in connection with future
acquisitions, existing equity holders may be diluted and earnings per share may decrease; and
|
•
|
managing the varying intellectual property protection strategies and other activities of an acquired company.
|
•
|
actual or anticipated fluctuations in our quarterly and annual financial results or the quarterly and annual financial
results of companies perceived to be similar to us;
|
•
|
changes in the market’s expectations about operating results;
|
•
|
operating results failing to meet market expectations in a particular period, which could impact the market price our Common
Shares;
|
•
|
operating and stock price performance of other companies that investors deem comparable to us;
|
•
|
changes in laws and regulations affecting our businesses;
|
•
|
commencement of, or involvement in, litigation involving the Company;
|
•
|
changes in our capital structure, such as future issuances of securities or the incurrence of debt;
|
•
|
any significant change in our Board of Directors or management;
|
•
|
sales of substantial amounts of our Common Shares by the Company, Cantor, the Investor, or our directors, executive officers
or significant shareholders or the perception that such sales could occur; and
|
•
|
general economic and political conditions such as recessions, interest rates, fuel prices, international currency
fluctuations and acts of war or terrorism.
|
•
|
a classified Board of Directors with staggered three-year terms;
|
•
|
the ability of our Board of Directors to determine the powers, preferences and rights of preference shares and to cause us to
issue the preference shares without shareholder approval; and
|
•
|
requiring advance notice for shareholder proposals and nominations and placing limitations on convening shareholder meetings.
|
•
|
a number of Common Shares which, when aggregated with all other Common Shares then beneficially owned by Cantor and its
affiliates (as calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder), would result in Cantor beneficially owning Common Shares equal to (but not exceeding) the Beneficial Ownership Cap;
|
•
|
(i) the total volume of Common Shares as reported by Bloomberg through its “VWAP” function during the applicable period
(subject to adjustment in the case that the price of our Common Shares falls below a
|
•
|
the number of Common Shares set forth in any VWAP Purchase Notice, representing the Company’s good faith estimate of the
number of Common Shares equivalent to the VWAP Purchase Share Request during the applicable period on the date on which such Common Shares are delivered to Cantor under the Purchase Agreement (the “VWAP Purchase Date”).
|
•
|
the accuracy in all material respects of the representations and warranties of the Company included in the Purchase
Agreement;
|
•
|
the Company having performed, satisfied and complied in all material respects with all covenants, agreements and conditions
required by the Purchase Agreement to be performed, satisfied or complied with by the Company;
|
•
|
the aggregate market value of the Company’s outstanding Common Stock is equal to or greater than $25 million (determined
based on the closing price of the Company’s Common Stock on Nasdaq on the day prior to the delivery of a VWAP Purchase Notice and the number of outstanding shares on such date);
|
•
|
the registration statement that includes this prospectus (and any one or more additional registration statements filed with
the SEC that include Common Shares that may be issued and sold by the Company to Cantor under the Purchase Agreement) having been declared effective under the Securities Act by the SEC and not being subject to any stop order or
suspension by the SEC, FINRA or Nasdaq, and Cantor being
|
•
|
the absence of any material misstatement or omission in the registration statement that includes this prospectus (or in any
one or more additional registration statements filed with the SEC that include Common Shares that may be issued and sold by the Company to Cantor under the Purchase Agreement);
|
•
|
this prospectus and all reports, schedules, registrations, forms, statements, information and other documents required to
have been filed by the Company with the SEC pursuant to the reporting requirements of the Exchange Act having been filed with the SEC;
|
•
|
all of the Common Shares that have been registered with the SEC for resale having been approved for listing or quotation on
Nasdaq (or if the Common Shares are not then listed on Nasdaq, on any Principal Market), subject only to notice of issuance;
|
•
|
no condition, occurrence, state of facts or event constituting a Material Adverse Effect (as such term is defined in the
Purchase Agreement) shall have occurred and be continuing;
|
•
|
customary bankruptcy-related conditions; and
|
•
|
the receipt by Cantor of customary legal opinions, auditor comfort letters and bring-down legal opinions, and auditor comfort
letters as required under the Purchase Agreement.
|
•
|
the first day of the month next following the 36-month anniversary of the date of this prospectus;
|
•
|
the date on which Cantor shall have purchased Common Shares under the Purchase Agreement for an aggregate gross purchase
price equal to $50.0 million;
|
•
|
the date on which the Common Shares shall have failed to be listed or quoted on Nasdaq or any other Principal Market;
|
•
|
the date on which the Company commences a voluntary bankruptcy case or any third party commences a bankruptcy proceeding
against the Company; and
|
•
|
the date on which a custodian is appointed for the Company in a bankruptcy proceeding for all or substantially all of its
property, or the Company makes a general assignment for the benefit of its creditors.
|
Assumed Trading
Price of Common Shares
|
| |
Number of
Shares Sold
Under the
Facility(1)
|
| |
Commitment
Fee Shares(2)
|
| |
Total Common
Shares Issued
to Holder
|
| |
Percentage of
Outstanding
Common Shares
After Giving Effect
to Issuances to
Holder(3)
|
| |
Proceeds
for Common
Shares Sold
Under the
Facility(4)
|
$1.51(5)
|
| |
4,178,331
|
| |
877,193
|
| |
5,055,524
|
| |
16.6%
|
| |
$6.1 million
|
$3.00
|
| |
4,178,331
|
| |
877,193
|
| |
5,055,524
|
| |
16.6%
|
| |
$12.2 million
|
$6.00
|
| |
4,178,331
|
| |
877,193
|
| |
5,055,524
|
| |
16.6%
|
| |
$24.4 million
|
$13.00
|
| |
3,965,107
|
| |
877,193
|
| |
4,842,300
|
| |
16.6%
|
| |
$50.0 million
|
(1)
|
The assumed average purchase prices are solely for illustrative purposes and are not intended to be estimates or predictions
of the future performance of our Common Shares.
|
(2)
|
Represents the Commitment Fee Shares, which are the 877,193 Common Shares we agreed to issue to the Holder as consideration
for its irrevocable commitment to purchase the Common Shares at our election in our sole discretion, from time to time after the date of this prospectus, upon the terms and subject to the satisfaction of the conditions set forth in the
Purchase Agreement.
|
(3)
|
The denominator used to calculate the percentages in this column is based on 25,334,721 Common Shares outstanding as of
August 26, 2022, adjusted to include the Common Shares (a) issued and sold to the Holder under the Facility and (b) issued to the Holder as Commitment Fee Shares.
|
(4)
|
Proceeds represent the illustrative aggregate purchase price to be received from the sale of all of the Common Shares issued
and sold to the Holder under the Facility, which is determined by multiplying the VWAP Purchase Price, which would be calculated as 97% of the assumed trading prices of the Common Shares shown at the various illustrative prices set
forth in the first column, by the number of shares set forth in the second column.
|
(5)
|
Represents the closing price of our Common Shares on Nasdaq on August 26, 2022.
|
•
|
the historical audited financial statements of Tuatara as of and for the year ended December 31, 2021 and as of
December 31, 2020 and for the period from January 24, 2020 through December 31, 2020;
|
•
|
the historical audited consolidated financial statements of Legacy SpringBig as of and for the years ended December 31,
2021 and December 31, 2020;
|
•
|
the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other
financial information included elsewhere in this prospectus; and
|
•
|
other information relating to Tuatara and Legacy SpringBig included in this prospectus, including the merger agreement and
the description of certain terms thereof set forth under the section entitled “Description of the Business Combination.”
|
a)
|
7,000,000 Contingent Shares if the closing price of the SpringBig common stock equals or exceeds $12.00 per share on any
twenty (20) trading days in a thirty (30)-trading day period at any time after the Closing Date and no later than 60 months following the Closing Date;
|
b)
|
2,250,000 Contingent Shares if the closing price of the SpringBig common stock equals or exceeds $15.00 per share on any
twenty (20) trading days in a thirty (30)-trading day period at any time after the Closing Date and no later than 60 months following the Closing Date; and
|
c)
|
1,250,000 Contingent Shares if the closing price of the SpringBig common stock equals or exceeds $18.00 per share on any
twenty (20) trading days in a thirty (30)-trading day period at any time after the Closing Date and no later than 60 months following the Closing Date.
|
•
|
Legacy SpringBig’s shareholders have the largest voting interest in SpringBig;
|
•
|
The board of directors of the post-combination company has seven members, and Legacy SpringBig shareholders have the
ability to nominate at least the majority of the members of the board of directors of the post-combination company;
|
•
|
Legacy SpringBig’s senior management is the senior management of the post-combination company;
|
•
|
The business of Legacy SpringBig will comprise the ongoing operations of SpringBig; and
|
•
|
Legacy SpringBig is the larger entity, in terms of substantive operations and employee base.
|
|
| |
Pro Forma
Combined
|
Weighted average shares calculations, basic and diluted
|
| |
|
Tuatara’s public shares
|
| |
1,752,388
|
Tuatara initial stockholders
|
| |
4,000,000
|
Subscription investors
|
| |
1,341,356
|
Legacy SpringBig stockholders(1)
|
| |
18,196,526
|
Weighted average shares outstanding – basic and diluted
|
| |
25,290,270
|
|
| |
|
Percentage of shares owned by Legacy SpringBig stockholders
|
| |
72.0%
|
Percentage of shares owned by Tuatara holders
|
| |
22.7%
|
Percentage of shares owned by subscription investors(1)
|
| |
5.3%
|
(1)
|
Of the shares owned by the subscription investors, 600,000 shares are attributable to affiliates of Tuatara and 10,000
shares are attributable to affiliates of Legacy SpringBig.
|
|
| |
Legacy
SpringBig
(Historical)
|
| |
Tuatara
(Historical)
|
| |
Transaction
Accounting
Adjustments
|
| |
|
| |
Pro Forma
Combined
|
Assets
|
| |
|
| |
|
| |
|
| |
|
| |
|
Current assets:
|
| |
|
| |
|
| |
|
| |
|
| |
|
Cash and cash equivalents
|
| |
$2,227
|
| |
$621
|
| |
$200,036
|
| |
(1)
|
| |
$22,687
|
|
| |
|
| |
|
| |
(191,438)
|
| |
(2)
|
| |
|
|
| |
|
| |
|
| |
(11,859)
|
| |
(3)
|
| |
|
|
| |
|
| |
|
| |
13,100
|
| |
(4)
|
| |
|
|
| |
|
| |
|
| |
10,000
|
| |
(8)
|
| |
|
Accounts receivable, net
|
| |
3,045
|
| |
—
|
| |
—
|
| |
|
| |
3,045
|
Contract assets
|
| |
364
|
| |
—
|
| |
—
|
| |
|
| |
364
|
Prepaid expenses and other current assets
|
| |
843
|
| |
260
|
| |
1,350
|
| |
(3)
|
| |
2,453
|
Total Current Assets
|
| |
6,479
|
| |
881
|
| |
21,189
|
| |
|
| |
28,549
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
Property, plant and equipment
|
| |
480
|
| |
—
|
| |
—
|
| |
|
| |
480
|
Deposits and other assets
|
| |
84
|
| |
—
|
| |
—
|
| |
|
| |
84
|
Investments held in Trust Account
|
| |
—
|
| |
200,036
|
| |
(200,036)
|
| |
(1)
|
| |
—
|
Total Assets
|
| |
$7,043
|
| |
$200,917
|
| |
$(178,847)
|
| |
|
| |
$29,113
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
Liabilities and Stockholders’ Equity
|
| |
|
| |
|
| |
|
| |
|
| |
|
Current Liabilities
|
| |
|
| |
|
| |
|
| |
|
| |
|
Accounts payable
|
| |
$412
|
| |
$1,555
|
| |
$795
|
| |
(3)
|
| |
$2,762
|
Related party payable
|
| |
5
|
| |
—
|
| |
—
|
| |
|
| |
5
|
Accrued wages and commissions
|
| |
805
|
| |
—
|
| |
—
|
| |
|
| |
805
|
Accrued expenses
|
| |
855
|
| |
108
|
| |
—
|
| |
|
| |
963
|
Contract liability
|
| |
450
|
| |
—
|
| |
—
|
| |
|
| |
450
|
Other liabilities
|
| |
57
|
| |
—
|
| |
—
|
| |
|
| |
57
|
Total current liabilities
|
| |
2,584
|
| |
1,663
|
| |
795
|
| |
|
| |
5,042
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
Warrant liability
|
| |
—
|
| |
9,440
|
| |
—
|
| |
|
| |
9,440
|
Convertible notes
|
| |
—
|
| |
—
|
| |
9,827
|
| |
(8)
|
| |
9,827
|
Deferred underwriting fee payable
|
| |
—
|
| |
7,000
|
| |
(7,000)
|
| |
(3)
|
| |
—
|
Total Liabilities
|
| |
2,584
|
| |
18,103
|
| |
3,622
|
| |
|
| |
24,309
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
Ordinary shares subject to possible redemption
|
| |
—
|
| |
200,000
|
| |
(200,000)
|
| |
(2)
|
| |
—
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
Shareholders’ Equity
|
| |
|
| |
|
| |
|
| |
|
| |
|
Series B Preferred
|
| |
5
|
| |
—
|
| |
(5)
|
| |
(5)
|
| |
—
|
Series A Preferred
|
| |
5
|
| |
—
|
| |
(5)
|
| |
(5)
|
| |
—
|
Series Seed Preferred
|
| |
7
|
| |
—
|
| |
(7)
|
| |
(5)
|
| |
—
|
Common stock
|
| |
14
|
| |
—
|
| |
—
|
| |
(2)
|
| |
3
|
|
| |
|
| |
|
| |
(14)
|
| |
(5)
|
| |
|
|
| |
|
| |
|
| |
2
|
| |
(5)
|
| |
|
|
| |
|
| |
|
| |
1
|
| |
(5)
|
| |
|
Additional paid in capital
|
| |
17,653
|
| |
—
|
| |
8,562
|
| |
(2)
|
| |
22,330
|
|
| |
|
| |
|
| |
13,100
|
| |
(4)
|
| |
|
|
| |
|
| |
|
| |
(17,158)
|
| |
(5)
|
| |
|
|
| |
|
| |
|
| |
173
|
| |
(8)
|
| |
|
Class B ordinary shares
|
| |
—
|
| |
1
|
| |
(1)
|
| |
(5)
|
| |
—
|
Accumulated deficit
|
| |
(13,225)
|
| |
(17,187)
|
| |
(4,304)
|
| |
(3)
|
| |
(17,529)
|
|
| | | | | |
17,187
|
| |
(5)
|
| | |||
Total Shareholders’ Equity
|
| |
4,459
|
| |
(17,186)
|
| |
17,531
|
| |
|
| |
4,804
|
Total Liabilities and Shareholders’ Equity
|
| |
$7,043
|
| |
$200,917
|
| |
$(178,847)
|
| |
|
| |
$29,113
|
|
| |
Legacy
SpringBig
(Historical)
|
| |
Tuatara
(Historical)
|
| |
Transaction
Accounting
Adjustments
|
| |
|
| |
Pro Forma
Combined
|
Revenue
|
| |
$24,024
|
| |
$—
|
| |
$—
|
| |
|
| |
$24,024
|
Cost of revenue
|
| |
6,929
|
| |
—
|
| |
—
|
| |
|
| |
6,929
|
Gross profit
|
| |
17,095
|
| |
—
|
| |
—
|
| |
|
| |
17,095
|
Selling, servicing and marketing
|
| |
10,185
|
| |
—
|
| |
—
|
| |
|
| |
10,185
|
Technology and software development
|
| |
8,410
|
| |
—
|
| |
—
|
| |
|
| |
8,410
|
General and administrative
|
| |
5,032
|
| |
—
|
| |
—
|
| |
|
| |
5,032
|
Operating expenses
|
| |
—
|
| |
2,035
|
| |
4,304
|
| |
(2)
|
| |
6,339
|
Total operating expenses
|
| |
23,627
|
| |
2,035
|
| |
4,304
|
| |
|
| |
29,966
|
Loss from operations
|
| |
(6,532)
|
| |
(2,035)
|
| |
(4,304)
|
| |
|
| |
(12,871)
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
Interest income
|
| |
3
|
| |
—
|
| |
—
|
| |
|
| |
3
|
Interest expense
|
| |
—
|
| |
—
|
| |
(1,247)
|
| |
(3)
|
| |
(1,247)
|
Forgiveness of PPP Loan
|
| |
781
|
| |
—
|
| |
—
|
| |
|
| |
781
|
Change in fair vaue of warrants
|
| |
—
|
| |
12,960
|
| |
—
|
| |
|
| |
12,960
|
Compensation expense
|
| |
—
|
| |
(2,400)
|
| |
—
|
| |
|
| |
(2,400)
|
Transaction costs allocated to warrants
|
| |
—
|
| |
(853)
|
| |
—
|
| |
|
| |
(853)
|
Interest earned on investments held in Trust Account
|
| |
—
|
| |
35
|
| |
(35)
|
| |
(1)
|
| |
—
|
(Loss) income before taxes
|
| |
(5,748)
|
| |
7,707
|
| |
(5,586)
|
| |
|
| |
(3,627)
|
Provision for taxes
|
| |
(2)
|
| |
—
|
| |
—
|
| |
(4)
|
| |
(2)
|
Net (loss) income
|
| |
$(5,750)
|
| |
$7,707
|
| |
$(5,586)
|
| |
|
| |
$(3,629)
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
Weighted average shares outstanding, basic
|
| |
13,385,267
|
| |
22,287,671
|
| |
3,002,599
|
| |
(5)
|
| |
25,290,270
|
Basic net (loss) income per share
|
| |
$(0.43)
|
| |
$0.35
|
| |
|
| |
|
| |
$(0.14)
|
Weighted average shares outstanding, diluted
|
| |
13,385,267
|
| |
22,369,863
|
| |
2,920,407
|
| |
(5)
|
| |
25,290,270
|
Diluted net (loss) income per share
|
| |
$(0.43)
|
| |
$0.34
|
| |
|
| |
|
| |
$(0.14)
|
1.
|
Basis of Presentation
|
•
|
Legacy SpringBig historical consolidated balance sheet as of December 31, 2021, as included elsewhere in this prospectus.
|
•
|
Tuatara’s historical unaudited consolidated balance sheet as of December 31, 2021, as included elsewhere in this
prospectus.
|
•
|
Legacy SpringBig historical consolidated statement of operations for the year ended December 31, 2021, included elsewhere
in this prospectus.
|
•
|
Tuatara’s historical statement of operations for the year ended December 31, 2021, included elsewhere in this prospectus.
|
2.
|
Adjustments to Unaudited Pro Forma Condensed Combined Balance Sheet as of December 31, 2021
|
3.
|
Adjustments to Unaudited Pro Forma Condensed Combined Statement of Operations for the Year Ended
December 31, 2021
|
4.
|
Net Income (Loss) per Share
|
|
| |
Pro Forma
Combined
|
Year Ended December 31, 2021
|
| |
|
Net loss
|
| |
$(3,629)
|
Weighted average shares outstanding - basic and diluted
|
| |
25,290,270
|
Basic and diluted net loss per share
|
| |
$(0.14)
|
|
| |
Pro Forma
Combined
|
Weighted average shares calculations, basic and diluted
|
| |
|
Tuatara’s public shares
|
| |
1,752,388
|
Tuatara initial stockholders
|
| |
4,000,000
|
Subscription investors
|
| |
1,341,356
|
Legacy SpringBig stockholders
|
| |
18,196,526
|
Weighted average shares outstanding – basic and diluted
|
| |
25,290,270
|
|
| |
Three Months ended June 30,
|
| |
Six Months ended June 30,
|
| |
Year ended December 31,
|
|||||||||
|
| |
2022
|
| |
2021
|
| |
2022
|
| |
2021
|
| |
2021
|
| |
2020
|
|
| |
(dollars in thousands)
|
|||||||||||||||
Revenue
|
| |
$6,584
|
| |
$5,804
|
| |
$12,948
|
| |
$11,013
|
| |
$24,024
|
| |
$15,183
|
Net Loss
|
| |
(2,611)
|
| |
(1,454)
|
| |
(5,476)
|
| |
(2,572)
|
| |
(5,750)
|
| |
(1,598)
|
Adjusted EBITDA
|
| |
(3,624)
|
| |
(1,330)
|
| |
(6,156)
|
| |
(2,321)
|
| |
(6,361)
|
| |
(1,582)
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Number of retail clients
|
| |
1,464
|
| |
1,018
|
| |
1,464
|
| |
1,018
|
| |
1,240
|
| |
759
|
Net revenue retention
|
| |
114%
|
| |
93%
|
| |
114%
|
| |
93%
|
| |
110%
|
| |
128%
|
Number of messages (million)
|
| |
480
|
| |
457
|
| |
915
|
| |
851
|
| |
1,861
|
| |
1,191
|
•
|
First, we specify a measurement period consisting of the trailing twelve months from the current period end. We measure our
net revenue retention rate on an ongoing, rolling basis over the prior twelve months rather than as a “point in time” metric.
|
•
|
Next, we calculate the numerator as the average monthly recurring revenue (“Base Revenue”), plus any changes in monthly
recurring revenue attributable to upgrades (“Upgrades”), less any lost monthly recurring revenue (“Losses”) and less any changes in monthly recurring revenue attributable downgrades (“Downgrades”).
|
•
|
We calculate the denominator as the average monthly recurring revenue for such trailing twelve month period (the “Base
Revenue” defined above).
|
•
|
Our net revenue retention rate is calculated as the quotient obtained by dividing the adjusted monthly recurring revenue
amount by the average monthly recurring revenue for such trailing twelve month period. The calculation can be summarized as follows:
|
•
|
although depreciation is a non-cash charge, the assets being depreciated may have to be replaced in the future, and neither
EBITDA nor Adjusted EBITDA reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements;
|
•
|
EBITDA and Adjusted EBITDA do not reflect changes in, or cash requirements for, our working capital needs; and
|
•
|
EBITDA and Adjusted EBITDA do not reflect tax payments that may represent a reduction in cash available.
|
|
| |
Three Months Ended June 30,
|
| |
Six Months Ended June 30,
|
||||||
|
| |
2022
|
| |
2021
|
| |
2022
|
| |
2021
|
Net loss
|
| |
$(2,611)
|
| |
$(1,454)
|
| |
$(5,476)
|
| |
$(2,572)
|
Interest income
|
| |
—
|
| |
(1)
|
| |
—
|
| |
(2)
|
Interest expense
|
| |
219
|
| |
—
|
| |
312
|
| |
—
|
Depreciation expense
|
| |
64
|
| |
6
|
| |
123
|
| |
12
|
EBITDA
|
| |
(2,328)
|
| |
(1,449)
|
| |
(5,041)
|
| |
(2,558)
|
Stock based compensation*
|
| |
1,045
|
| |
119
|
| |
1,226
|
| |
237
|
Business combination related bonus
|
| |
550
|
| |
—
|
| |
550
|
| |
—
|
Change in fair value of warrants
|
| |
(2,880)
|
| |
—
|
| |
(2,880)
|
| |
—
|
Change in fair value of senior secured convertible note
|
| |
(11)
|
| |
—
|
| |
(11)
|
| |
—
|
Adjusted EBITDA
|
| |
$(3,624)
|
| |
$(1,330)
|
| |
$(6,156)
|
| |
$(2,321)
|
*
|
Stock-based compensation is recorded in General and Administrative expenses.
|
|
| |
Year ended
December 31,
|
|||
|
| |
2020
|
| |
2021
|
|
| |
(dollars in thousands)
|
|||
Net Loss
|
| |
$(1,598)
|
| |
$(5,750)
|
Interest income
|
| |
(3)
|
| |
(3)
|
Depreciation expense
|
| |
19
|
| |
173
|
EBITDA
|
| |
(1,582)
|
| |
(5,580)
|
Forgiveness of PPP loan
|
| |
—
|
| |
(781)
|
Adjusted EBITDA
|
| |
(1,582)
|
| |
(6,361)
|
|
| |
|
| |
Three Months Ended June 30,
|
| |
|
|||
|
| |
2022
|
| |
2021
|
| |
Increase
(decrease)
|
| |
%
|
|
| |
|
| |
(in thousands)
|
| |
|
| |
|
Revenue
|
| |
$6,584
|
| |
$5,804
|
| |
$780
|
| |
13%
|
Cost of revenue
|
| |
1,998
|
| |
1,865
|
| |
133
|
| |
7%
|
Gross profit
|
| |
4,586
|
| |
3,939
|
| |
647
|
| |
16%
|
Operating expenses:
|
| |
|
| |
|
| |
|
| |
|
Selling, servicing and marketing
|
| |
3,105
|
| |
2,449
|
| |
656
|
| |
27%
|
Technology and software development
|
| |
2,910
|
| |
1,811
|
| |
1,099
|
| |
61%
|
General and administrative
|
| |
3,790
|
| |
1,128
|
| |
2,662
|
| |
236%
|
Depreciation expense
|
| |
64
|
| |
6
|
| |
58
|
| |
nm
|
Total operating expenses
|
| |
9,869
|
| |
5,394
|
| |
4,475
|
| |
83%
|
Loss from operations
|
| |
(5,283)
|
| |
(1,455)
|
| |
(3,828)
|
| |
263%
|
Interest income
|
| |
—
|
| |
1
|
| |
(1)
|
| |
nm
|
Interest expense
|
| |
(219)
|
| |
—
|
| |
(219)
|
| |
nm
|
Change in fair value of warrants
|
| |
2,880
|
| |
—
|
| |
2,880
|
| |
nm
|
Change in fair value of senior secured convertible note
|
| |
11
|
| |
—
|
| |
11
|
| |
nm
|
Net loss before taxes
|
| |
(2,611)
|
| |
(1,454)
|
| |
(1,157)
|
| |
80%
|
Provision for income taxes
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Net loss before taxes
|
| |
$(2,611)
|
| |
$(1,454)
|
| |
$(1,157)
|
| |
80%
|
|
| |
|
| |
Six Months Ended June 30,
|
| |
|
|||
|
| |
2022
|
| |
2021
|
| |
Increase
(decrease)
|
| |
%
|
|
| |
|
| |
(in thousands)
|
| |
|
| |
|
Revenue
|
| |
$12,948
|
| |
$11,013
|
| |
$1,935
|
| |
18%
|
Cost of revenue
|
| |
3,841
|
| |
3,459
|
| |
382
|
| |
11%
|
Gross profit
|
| |
9,107
|
| |
7,554
|
| |
1,553
|
| |
21%
|
Operating expenses:
|
| |
|
| |
|
| |
|
| |
|
Selling, servicing and marketing
|
| |
6,048
|
| |
4,520
|
| |
1,528
|
| |
34 %
|
Technology and software development
|
| |
5,547
|
| |
3,376
|
| |
2,171
|
| |
64%
|
General and administrative
|
| |
5,444
|
| |
2,220
|
| |
3,224
|
| |
145%
|
Depreciation expense
|
| |
123
|
| |
12
|
| |
111
|
| |
nm
|
Total operating expenses
|
| |
17,162
|
| |
10,128
|
| |
7,034
|
| |
69%
|
Loss from operations
|
| |
(8,055)
|
| |
(2,574)
|
| |
(5,481)
|
| |
213%
|
Interest income
|
| |
—
|
| |
2
|
| |
(2)
|
| |
nm
|
Interest expense
|
| |
(312)
|
| |
—
|
| |
(312)
|
| |
nm
|
Change in fair value of warrants
|
| |
2,880
|
| |
—
|
| |
2,880
|
| |
nm
|
Change in fair value of senior secured convertible note
|
| |
11
|
| |
—
|
| |
11
|
| |
nm
|
Net loss before taxes
|
| |
(5,476)
|
| |
(2,572)
|
| |
(2,904)
|
| |
113%
|
Provision for income taxes
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Net loss before taxes
|
| |
$(5,476)
|
| |
$(2,572)
|
| |
$(2,904)
|
| |
113%
|
|
| |
Year Ended December 31,
|
| |
Change
|
||||||
|
| |
2020
|
| |
2021
|
| |
($)
|
| |
(%)
|
|
| |
(dollars in thousands)
|
|||||||||
Revenue
|
| |
$15,183
|
| |
$24,024
|
| |
$8,841
|
| |
58%
|
Cost of revenue
|
| |
4,978
|
| |
6,929
|
| |
1,951
|
| |
39%
|
Gross profit
|
| |
10,205
|
| |
17,095
|
| |
6,890
|
| |
68%
|
|
| |
Year Ended December 31,
|
| |
Change
|
||||||
|
| |
2020
|
| |
2021
|
| |
($)
|
| |
(%)
|
|
| |
(dollars in thousands)
|
|||||||||
Operating expenses:
|
| |
|
| |
|
| |
|
| |
|
Selling, servicing and marketing
|
| |
$4,843
|
| |
$10,185
|
| |
$342
|
| |
110%
|
Technology and software development
|
| |
4,391
|
| |
8,410
|
| |
4,019
|
| |
92%
|
General and administrative
|
| |
2,553
|
| |
4,859
|
| |
2,306
|
| |
90%
|
Depreciation expense
|
| |
19
|
| |
173
|
| |
154
|
| |
810%
|
Total operating expenses
|
| |
11,806
|
| |
23,627
|
| |
11,821
|
| |
110%
|
Loss from operations
|
| |
(1,601)
|
| |
(6,532)
|
| |
(4,931)
|
| |
308%
|
Interest and other income
|
| |
3
|
| |
784
|
| |
781
|
| |
26033%
|
Net Income before tax
|
| |
(1,598)
|
| |
(5,748)
|
| |
(4,150)
|
| |
260%
|
Provision for income taxes
|
| |
—
|
| |
2
|
| |
—
|
| |
—
|
Net Loss
|
| |
(1,598)
|
| |
(5,750)
|
| |
(4,152)
|
| |
260%
|
|
| |
June 30, 2022
|
| |
December 31, 2021
|
Cash and cash equivalents
|
| |
$ 14,179
|
| |
$ 2,227
|
Accounts receivable, net
|
| |
3,597
|
| |
3,045
|
Working capital
|
| |
14,025
|
| |
3,979
|
|
| |
Six Months Ended June 30,
|
|||
|
| |
2022
|
| |
2021
|
Statement of Cash Flows Data:
|
| |
|
| |
|
Total cash (used in) provided by:
|
| |
|
| |
|
Operating activities
|
| |
$(4,952)
|
| |
$(2,452)
|
Investing activities
|
| |
(363)
|
| |
(317)
|
Financing activities
|
| |
17,267
|
| |
—
|
Increase (decrease) in cash and cash equivalents
|
| |
$11,952
|
| |
$(2,769)
|
|
| |
Year ended December 31,
|
|||
|
| |
2020
|
| |
2021
|
|
| |
(dollars in thousands)
|
|||
Net cash used in operating activities
|
| |
$(1,006)
|
| |
$(7,884)
|
Net cash used in investing activities
|
| |
(195)
|
| |
(374)
|
Net cash provided by financing activities
|
| |
9,025
|
| |
38
|
Net increase (decrease) in cash
|
| |
7,824
|
| |
(8,220)
|
|
| |
Payments Due by Period
|
||||||||||||
|
| |
Total
|
| |
Less
than
1 year
|
| |
1 - 3
years
|
| |
3 - 5
years
|
| |
More
than
5 years
|
|
| |
(dollars in thousands)
|
||||||||||||
Operating lease obligations
|
| |
1,098
|
| |
471
|
| |
627
|
| |
—
|
| |
—
|
(1)
|
Estimate based on average marketing spend in similar industries.
|
1
|
New Frontier Data, December 2020
|
•
|
Cannabis retailers and brands lack actionable data and need better insight and recommendation technology.
|
•
|
Purpose-built marketing technology and targeting is necessary to improve consumer acquisition and retention.
|
•
|
The cannabis industry lacks robust fintech solutions, including processing of payments and consumer credit (pending
regulatory developments around these solutions in the cannabis industry).
|
•
|
Cannabis retailers are facing competition from and losing consumer loyalty to online marketplaces.
|
•
|
Retailers need improved software tools to manage their operations more efficiently, including POS, HR/team management,
inventory management, working capital financing, menu/displays management.
|
•
|
Powerful POS Integration Sync: Powerful POS integrations allow us to provide real-time redemptions for both loyalty rewards
and promotional offers, real-time campaign analytics, and deep transaction data.
|
•
|
Customizable Permission Settings: Our platform enables clients to establish their own levels of user permissions for their
retail and marketing staff to ensure the correct people have the correct access to data and marketing tools.
|
•
|
Datahub: The robust data warehouse provides clients with access to all of their data and allows them to create their own
insights.
|
•
|
Insight Data Dashboards: Our customizable dashboards help clients conveniently visualize the most meaningful data and
organize it for easy review.
|
•
|
Budz: Our customer referral engine, allows retailers’ best customers to become brand ambassadors by referring new customers
to their favorite stores.
|
•
|
Feedback by SpringBig: Our customer feedback tool allows retailers to capture post-transaction feedback about their store,
products, and staff.
|
•
|
Autoconnect: Allow retailers to reach their consumers at critical stages during the consumer buying journey including
win-back, abandon cart, and purchase behavior messaging.
|
Name
|
| |
Age
|
| |
Position
|
Executive Officers
|
| |
|
| |
|
Jeffrey Harris
|
| |
58
|
| |
Chief Executive Officer and Director
|
Paul Sykes
|
| |
57
|
| |
Chief Financial Officer
|
Navin Anand
|
| |
47
|
| |
Chief Technology Officer
|
Non-Employee Directors
|
| |
|
| |
|
Steven Bernstein
|
| |
61
|
| |
Director
|
Patricia Glassford
|
| |
59
|
| |
Director
|
Amanda Lannert
|
| |
49
|
| |
Director
|
Phil Schwarz
|
| |
44
|
| |
Director
|
Sergey Sherman
|
| |
52
|
| |
Director
|
Jon Trauben
|
| |
56
|
| |
Director
|
•
|
Class I, which consists of Amanda Lannert and Jon Trauben, whose terms will expire at the SpringBig’s first annual meeting of
shareholders to be held after the business combination;
|
•
|
Class II, which consists of Patricia Glassford and Phil Schwarz, whose terms will expire at SpringBig’s second annual meeting
of shareholders to be held after the business combination; and
|
•
|
Class III, which consists of Steven Bernstein, Jeffrey Harris, and Sergey Sherman, whose terms will expire at SpringBig’s
third annual meeting of shareholders to be held after the business combination.
|
•
|
approve the hiring, discharging and compensation of SpringBig’s independent auditors;
|
•
|
oversee the work of SpringBig’s independent auditors;
|
•
|
approve engagements of the independent auditors to render any audit or permissible non-audit services;
|
•
|
review the qualifications, independence and performance of the independent auditors;
|
•
|
review SpringBig’s financial statements and review SpringBig’s critical accounting policies and estimates;
|
•
|
review the adequacy and effectiveness of SpringBig’s internal controls; and
|
•
|
review and discuss with management and the independent auditors the results of SpringBig’s annual audit, SpringBig’s
quarterly financial statements and SpringBig’s publicly filed reports.
|
•
|
review and recommend policies relating to compensation and benefits of SpringBig’s officers and employees;
|
•
|
review and approve corporate goals and objectives relevant to compensation of SpringBig’s chief executive officer and other
senior officers;
|
•
|
evaluate the performance of SpringBig’s officers in light of established goals and objectives;
|
•
|
recommend compensation of SpringBig’s officers based on its evaluations; and
|
•
|
administer the issuance of stock options and other awards under SpringBig’s stock plans.
|
•
|
evaluate and make recommendations regarding the organization and governance of the Board of Directors and its committees;
|
•
|
assess the performance of members of the Board of Directors and make recommendations regarding committee and chair
assignments;
|
•
|
recommend desired qualifications for Board of Directors membership and conduct searches for potential members of the Board of
Directors; and
|
•
|
review and make recommendations with regard to SpringBig’s corporate governance guidelines.
|
•
|
Jeffrey Harris, SpringBig’s Chief Executive Officer;
|
•
|
Paul Sykes, SpringBig’s Chief Financial Officer; and
|
•
|
Navin Anand, SpringBig’s Chief Technology Officer.
|
Name and Principal Position
|
| |
Year
|
| |
Salary
($)
|
| |
Bonus
($)
|
| |
Option
Awards
($)(3)
|
| |
Non-Equity
Incentive Plan
Compensation
($)
|
| |
All Other
Compensation
($)
|
| |
Total
($)
|
Jeffrey Harris
Chief Executive Officer
|
| |
2021
|
| |
$265,000
|
| |
$—
|
| |
$—
|
| |
$—
|
| |
$—
|
| |
$265,000
|
|
2020
|
| |
$222,889
|
| |
$—
|
| |
$93,750
|
| |
$—
|
| |
$—
|
| |
$316,639
|
||
Paul Sykes
Chief Financial Officer(1)
|
| |
2021
|
| |
$172,944
|
| |
$90,000
|
| |
$281,250
|
| |
$—
|
| |
$—
|
| |
$544,194
|
Navin Anand
Chief Technology Officer(2)
|
| |
2021
|
| |
$139,838
|
| |
$40,000
|
| |
$206,250
|
| |
$—
|
| |
$—
|
| |
$386,088
|
(1)
|
Mr. Sykes was appointed Chief Financial Officer of Legacy SpringBig effective April 7, 2021.
|
(2)
|
Mr. Anand was appointed Chief Technology Officer of Legacy SpringBig effective April 12, 2021.
|
(3)
|
Amounts represent the aggregate grant date fair value of stock options granted to our named executive officers computed in
accordance with ASC Topic 718. Assumptions used to calculate these amounts are included in Note 7 – Common Stock Options accompanying the historical audited consolidated financial statements of SpringBig included in this prospectus.
|
|
| |
|
| |
Option Awards
|
|||||||||||||||
|
| |
Grant Date
|
| |
Vesting
Commencement
Date
|
| |
|
| |
Number of
securities
underlying
unexercised
options
(#) exercisable
|
| |
Number of
securities
underlying
unexercised
options
(#) unexercisable
|
| |
Option
exercise
price
($)
|
| |
Option
expiration
date
|
Jeffrey Harris
|
| |
3/17/2019
|
| |
3/17/2021
|
| |
(1)
|
| |
350,000
|
| |
350,000
|
| |
$0.31
|
| |
3/17/2029
|
|
| |
12/2/2020
|
| |
12/2/2021
|
| |
(1)
|
| |
31,250
|
| |
93,720
|
| |
$0.75
|
| |
12/2/2030
|
Paul Sykes
|
| |
6/21/2021
|
| |
4/7/2021
|
| |
(2)
|
| |
131,250
|
| |
243,750
|
| |
$0.75
|
| |
6/21/2031
|
Navin Anand
|
| |
6/21/2021
|
| |
4/12/2021
|
| |
(2)
|
| |
96,250
|
| |
178,750
|
| |
$0.75
|
| |
6/21/2031
|
(1)
|
Represents an option vesting with respect to 25% of the shares subject to the option on each one-year anniversary of the grant
date.
|
(2)
|
Represents an option vesting with respect to (a) 35% of the shares subject to the option on December 31, 2021, (b) 15% of the
shares subject to the option as of the closing of the business combination and (c) 50% of the shares subject to the option ratably over 24 months following the business combination.
|
•
|
an annual grant of 25,000 RSUs for each Board member;
|
•
|
an annual cash retainer of $75,000 for each Board member;
|
•
|
an annual cash committee chair retainer for each committee chair:
|
○
|
Audit: $17,000
|
○
|
Compensation: $10,000
|
○
|
Nominating and Corporate Governance: $9,000
|
•
|
an annual cash committee chair retainer for each committee member:
|
○
|
Audit: $6,000
|
○
|
Compensation: $3,500
|
○
|
Nominating and Corporate Governance: $3,000
|
•
|
Voting and Support Agreements. In connection with the signing of the merger
agreement, on November 8, 2021, Tuatara, Legacy SpringBig and certain shareholders and optionholders of Legacy SpringBig and Tuatara entered into voting and support agreements, pursuant to which such Legacy SpringBig shareholders agreed
to vote all of their shares in Legacy SpringBig in favor of the merger agreement and related transactions and to take certain other actions in support of the merger agreement and related transactions. The Legacy SpringBig voting and
support members also each agreed, with certain exceptions, to a lock-up for a period of 180 days after the closing with respect to any securities of the Company that they receive as merger consideration under the merger agreement.
|
•
|
Subscription Agreements. Certain investors entered in subscription agreements
pursuant to which Tuatara agreed to issue and sell to the subscription investors, in the aggregate, $13,100,000 of common stock of
|
•
|
Amended and Restated Registration Rights Agreement. In connection with the
consummation of the merger agreement and the business combination, on June 14, 2022, SpringBig and certain holders entered in an amended and restated registration rights agreement, pursuant to which such holders are able to make a
written demand for registration under the Securities Act of all or a portion of their registrable securities, subject to a maximum of three (3) such demand registrations for our sponsor and four (4) such demand registrations for the
other investors thereto, in each case so long as such demand includes a number of registrable securities with a total offering price in excess of $10 million. Any such demand may be in the form of an underwritten offering, it being
understood that we will not be able to conduct more than two underwritten offerings where the expected aggregate proceeds are less than $25 million but in excess of $10 million in any 12-month period.
|
•
|
Sponsor Escrow Agreement. The Sponsor, Tuatara and certain independent members of
the pre-business combination board of directors entered into an escrow agreement (“Sponsor Escrow Agreement”) at the closing of the business combination pursuant to which the Sponsor and certain members of the pre-business combination
board of directors deposited an aggregate of 1,000,000 shares of the Company’s Common Stock (“Sponsor Earnout Shares”) into escrow. The Sponsor Escrow Agreement provides that such Sponsor Earnout Shares will either be released to the
Sponsor if the closing price of the Company’s Common Stock equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations, and recapitalizations) on any twenty (20) trading days in a thirty
(30)-trading-day period at any time after the closing date and by the fifth anniversary of the closing date. The Sponsor Earnout Shares will be terminated and canceled by the Company if such condition is not met at any time after the
closing date and by the fifth anniversary of the closing date.
|
•
|
each person known by the Company to be the beneficial owner of more than 5% of outstanding Common Shares;
|
•
|
each of the Company’s named executive officers and directors; and
|
•
|
all executive officers and directors of the Company as a group.
|
Name of Beneficial Owner
|
| |
Number of Shares
of Common Stock
Beneficially Owned
|
| |
Percentage of
Outstanding
Common Stock(1)
|
5% Shareholders
|
| |
|
| |
|
Medici Holdings V, Inc.
|
| |
4,743,120
|
| |
18.7%
|
Tuatara Capital Fund II, L.P.(2)
|
| |
4,470,000
|
| |
17.6%
|
TVC Capital IV, L.P.(3)
|
| |
2,495,499
|
| |
9.9%
|
Altitude Investment Partners, LP(4)
|
| |
1,528,295
|
| |
6.0%
|
Gamson Family Revocable Trust
|
| |
1,306,326
|
| |
5.2%
|
Executive Officer and Directors of the Company
|
| |
|
| |
|
Jeffrey Harris(5)
|
| |
5,242,254
|
| |
20.7%
|
Paul Sykes(6)
|
| |
115,635
|
| |
*
|
Navin Anand(7)
|
| |
95,110
|
| |
*
|
Steven Bernstein
|
| |
—
|
| |
*
|
Patricia Glassford
|
| |
—
|
| |
*
|
Amanda Lannert
|
| |
—
|
| |
*
|
Phil Schwarz(8)
|
| |
474,312
|
| |
1.9%
|
Sergey Sherman
|
| |
—
|
| |
*
|
Jon Trauben
|
| |
—
|
| |
*
|
All directors and named executive officers of SpringBig
as a group post-business combination (9 individuals):
|
| |
5,927,311
|
| |
23.4%
|
*
|
Represents beneficial ownership of less than 1% of the outstanding shares of our common stock.
|
(1)
|
The percentage of beneficial ownership of the Company is calculated based on 25,334,721 shares of common stock outstanding
as of August 26, 2022, which includes the shares of common stock issued to the stockholders of SpringBig in connection with the business combination. Unless otherwise indicated, the business address noted for each of the foregoing
entities or individuals is 621 NW 53rd Street, Ste. 260, Boca Raton, FL 33487.
|
(2)
|
Includes 3,870,000 shares of common stock held by TCAC Sponsor, LLC (the “Sponsor”) and 600,000 shares of common stock held by
Tuatara Capital Fund II, L.P. Tuatara Capital Fund II, L.P. (“Fund II”) is the sole member of TCAC Sponsor, LLC. Accordingly, shares of common stock held by TCAC Sponsor, LLC may be attributed to Fund II. Fund II is controlled by a
board of managers comprised of three individuals - Albert Foreman, Mark Zittman and Marc Riiska. Any action by our sponsor with respect to our company or the founders’ shares, including voting and dispositive decisions, requires a
majority vote of the managers of the board of managers of Fund II. Under the so-called “rule of three,” because voting and dispositive decisions are made by a majority of Fund II’s managers, none of the managers is deemed to be a
beneficial owner of our sponsor’s securities, even those in which he holds a pecuniary interest. Accordingly, none of the managers is deemed to have or share beneficial ownership of the founders’ shares held by the Sponsor.
|
(3)
|
TVC Capital IV, L.P. is an affiliate of TVC Capital Partners IV, L.P. Each of TVC Capital IV LP and TVC Capital Partners IV LP
is directly controlled by TVC Capital IV GP, LLC (“GP IV”). Each of Steven Hamerslag and Jeb S. Spencer is a managing member of GP IV and may be deemed to have shared voting and dispositive power over the shares held by the foregoing
entities. The foregoing is not an admission by any of Steven Hamerslag and Jeb S. Spencer that he is the beneficial owner of the shares held by the foregoing entities. The address for each of the foregoing persons is 11710 El Camino
Real, Suite 100, San Diego, CA 92130.
|
(4)
|
The address for Altitude Investment Partners, LP is 73 Bal Bay Drive, Bal Harbor, FL 33154.
|
(5)
|
Includes the shares of common stock held by Medici Holdings V, Inc., an estate planning vehicle through which Mr. Harris
shares ownership with family members of Mr. Harris and for which Mr. Harris may be deemed to have investment discretion and voting power.
|
(6)
|
Includes 9,264 options exercisable for shares of common stock within 60 days.
|
(7)
|
Includes 6,794 options exercisable for shares of common stock within 60 days.
|
Name of Selling Stockholder
|
| |
Number of Shares of
Common Stock
Owned Prior to Offering
|
| |
Maximum Number of
Shares of Common
Stock to be Offered
Pursuant to this
Prospectus
|
| |
Number of Shares of
Common Stock
Owned After Offering
|
||||||
|
| |
Number(1)
|
| |
Percent(2)
|
| |
|
| |
Number(3)
|
| |
Percent(2)
|
CF Principal Investments LLC(4)
|
| |
0
|
| |
—
|
| |
5,055,524
|
| |
0
|
| |
—
|
(1)
|
Number of shares owned prior to the Offering is as of July 11, 2022. In accordance with Rule 13d-3(d) under the Exchange Act,
we have excluded from the number of shares beneficially owned prior to the offering all of the shares that Cantor may be required to purchase under the Purchase Agreement, because the issuance of such Shares is solely at our discretion
and is subject to conditions contained in the Purchase Agreement, the satisfaction of which are entirely outside of Cantor’s control, including the registration statement that includes this prospectus becoming and remaining effective.
Furthermore, the VWAP Purchases of common stock are subject to certain agreed upon maximum amount limitations set forth in the Purchase Agreement. Also, the Purchase Agreement prohibits us from issuing and selling any Shares to Cantor
to the extent such Shares, when aggregated with all other Shares then beneficially owned by Cantor, would cause Cantor’s beneficial ownership of our common stock to exceed 8%. The Purchase Agreement also prohibits us from issuing or
selling Shares under the Purchase Agreement in excess of the 19.99% Exchange Cap, unless we obtain stockholder approval to do so. Neither the Beneficial Ownership Limitation nor the Exchange Cap (to the extent applicable under Nasdaq
rules) may be amended or waived under the Purchase Agreement. As of July 11, 2022, Cantor's affiliate, CF&CO, owned 518,172 Common Shares.
|
(2)
|
Applicable percentage ownership is based on 25,334,721 Common Shares outstanding as of August 26, 2022.
|
(3)
|
Assumes the sale of all Shares being offered pursuant to this prospectus.
|
(4)
|
CF Group Management, Inc. (“CFGM”) is the managing general partner of Cantor Fitzgerald, L.P. (“CFLP”) and directly or
indirectly controls the managing general partner of Cantor Fitzgerald Securities (“CFS”), the sole member of Cantor. Howard Lutnick is Chairman and Chief Executive of CFGM and trustee of CFGM’s sole stockholder. CFLP, indirectly, holds
a majority of the ownership interests in CFS, and therefore also indirectly, Cantor. As such, each of CFLP, CFGM, CFS and Mr. Lutnick may be deemed to have beneficial ownership of the securities directly held by Cantor. Each such entity
or person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly. The foregoing should not be construed in and of itself as an admission
by any of CFLP, CFGM, CFS or Mr. Lutnick as to beneficial ownership of the securities beneficially owned, directly, Cantor. The business address of Cantor is 110 East 59th Street, New York, NY 10022.
|
•
|
in whole and not in part;
|
•
|
at a price of $0.01 per public warrant;
|
•
|
upon not less than thirty (30) days’ prior written notice of redemption to each public warrant holder; and
|
•
|
if, and only if, the reported last sales price of the shares of common stock equals or exceeds $18.00 per share (as adjusted
for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date SpringBig sends
the notice of redemption to the public warrant holders (the “Reference Value”).
|
•
|
in whole and not in part;
|
•
|
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption, provided that holders will be able to
exercise their warrants on a cashless basis prior to redemption based on the redemption date and the “fair market value” of our Common Shares;
|
•
|
if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares
issuable upon exercise or the exercise price of a warrant); and
|
•
|
if the Reference Value is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon
exercise or the exercise price of a warrant), the private placement warrants must also concurrently be called for redemption on the same terms as the outstanding public warrants.
|
|
| |
Fair Market Value of Shares of Common Stock
|
||||||||||||||||||||||||
Redemption Date
(period to expiration of warrants)
|
| |
$10.00
|
| |
$11.00
|
| |
$12.00
|
| |
$13.00
|
| |
$14.00
|
| |
$15.00
|
| |
$16.00
|
| |
$17.00
|
| |
$18.00
|
60 months
|
| |
0.261
|
| |
0.281
|
| |
0.297
|
| |
0.311
|
| |
0.324
|
| |
0.337
|
| |
0.348
|
| |
0.358
|
| |
0.361
|
57 months
|
| |
0.257
|
| |
0.277
|
| |
0.294
|
| |
0.310
|
| |
0.324
|
| |
0.337
|
| |
0.348
|
| |
0.358
|
| |
0.361
|
54 months
|
| |
0.252
|
| |
0.272
|
| |
0.291
|
| |
0.307
|
| |
0.322
|
| |
0.335
|
| |
0.347
|
| |
0.357
|
| |
0.361
|
51 months
|
| |
0.246
|
| |
0.268
|
| |
0.287
|
| |
0.304
|
| |
0.320
|
| |
0.333
|
| |
0.346
|
| |
0.357
|
| |
0.361
|
48 months
|
| |
0.241
|
| |
0.263
|
| |
0.283
|
| |
0.301
|
| |
0.317
|
| |
0.332
|
| |
0.344
|
| |
0.356
|
| |
0.361
|
45 months
|
| |
0.235
|
| |
0.258
|
| |
0.279
|
| |
0.298
|
| |
0.315
|
| |
0.330
|
| |
0.343
|
| |
0.356
|
| |
0.361
|
42 months
|
| |
0.228
|
| |
0.252
|
| |
0.274
|
| |
0.294
|
| |
0.312
|
| |
0.328
|
| |
0.342
|
| |
0.355
|
| |
0.361
|
39 months
|
| |
0.221
|
| |
0.246
|
| |
0.269
|
| |
0.290
|
| |
0.309
|
| |
0.325
|
| |
0.340
|
| |
0.354
|
| |
0.361
|
36 months
|
| |
0.213
|
| |
0.239
|
| |
0.263
|
| |
0.285
|
| |
0.305
|
| |
0.323
|
| |
0.339
|
| |
0.353
|
| |
0.361
|
33 months
|
| |
0.205
|
| |
0.232
|
| |
0.257
|
| |
0.280
|
| |
0.301
|
| |
0.320
|
| |
0.337
|
| |
0.352
|
| |
0.361
|
30 months
|
| |
0.196
|
| |
0.224
|
| |
0.250
|
| |
0.274
|
| |
0.297
|
| |
0.316
|
| |
0.335
|
| |
0.351
|
| |
0.361
|
27 months
|
| |
0.185
|
| |
0.214
|
| |
0.242
|
| |
0.268
|
| |
0.291
|
| |
0.313
|
| |
0.332
|
| |
0.350
|
| |
0.361
|
24 months
|
| |
0.173
|
| |
0.204
|
| |
0.233
|
| |
0.260
|
| |
0.285
|
| |
0.308
|
| |
0.329
|
| |
0.348
|
| |
0.361
|
21 months
|
| |
0.161
|
| |
0.193
|
| |
0.223
|
| |
0.252
|
| |
0.279
|
| |
0.304
|
| |
0.326
|
| |
0.347
|
| |
0.361
|
18 months
|
| |
0.146
|
| |
0.179
|
| |
0.211
|
| |
0.242
|
| |
0.271
|
| |
0.298
|
| |
0.322
|
| |
0.345
|
| |
0.361
|
15 months
|
| |
0.130
|
| |
0.164
|
| |
0.197
|
| |
0.230
|
| |
0.262
|
| |
0.291
|
| |
0.317
|
| |
0.342
|
| |
0.361
|
12 months
|
| |
0.111
|
| |
0.146
|
| |
0.181
|
| |
0.216
|
| |
0.250
|
| |
0.282
|
| |
0.312
|
| |
0.339
|
| |
0.361
|
9 months
|
| |
0.090
|
| |
0.125
|
| |
0.162
|
| |
0.199
|
| |
0.237
|
| |
0.272
|
| |
0.305
|
| |
0.336
|
| |
0.361
|
6 months
|
| |
0.065
|
| |
0.099
|
| |
0.137
|
| |
0.178
|
| |
0.219
|
| |
0.259
|
| |
0.296
|
| |
0.331
|
| |
0.361
|
3 months
|
| |
0.034
|
| |
0.065
|
| |
0.104
|
| |
0.150
|
| |
0.197
|
| |
0.243
|
| |
0.286
|
| |
0.326
|
| |
0.361
|
0 months
|
| |
—
|
| |
—
|
| |
0.042
|
| |
0.115
|
| |
0.179
|
| |
0.233
|
| |
0.281
|
| |
0.323
|
| |
0.361
|
(i)
|
If the Earnout Trigger Event occurs prior to the one-year anniversary of the Effective Time and results in an Earnout Trigger
Price that is greater than $10.00, but less than $12.00, then only a portion of the First Tranche Shares shall be issued to the Legacy SpringBig shareholders and Engaged Option Holders equal to the First Tranche Shares multiplied by a
fraction calculated as: (A) the numerator of which shall be the Earnout Trigger Price minus $10 and (B) the denominator of which is 2.
|
(ii)
|
If the Earnout Trigger Event occurs after the one-year anniversary of the Closing Date and results in an Earnout Trigger
Price that is less than $12.00, then none of the Contingent Shares shall be issued.
|
(iii)
|
If the Earnout Trigger Event occurs at any time during the 60 months following the effective time and results in an Earnout
Trigger Price that is equal to or greater than $15.00, but less than $18.00, then only the First Tranche Shares and Second Tranche Shares shall be issued to the Legacy SpringBig shareholders and Engaged Option Holders.
|
(iv)
|
If the Earnout Trigger Event occurs at any time during the 60 months following the effective time and results in an Earnout
Trigger Price equal to or greater than $18.00, then all of the Contingent Shares shall be issued to the Legacy SpringBig shareholders and Engaged Option Holders.
|
•
|
A shareholder who owns fifteen percent or more of SpringBig’s outstanding voting stock (otherwise known as an “interested
shareholder”);
|
•
|
an affiliate of an interested shareholder; or
|
•
|
an associate of an interested shareholder, for three (3) years following the date that the shareholder became an interested
shareholder.
|
•
|
SpringBig’s Board of Directors approves the transaction that made the shareholder an “interested shareholder,” prior to the
date of the transaction;
|
•
|
after the completion of the transaction that resulted in the shareholder becoming an interested shareholder, that shareholder
owned at least 85% of SpringBig’s voting stock outstanding at the time the transaction commenced, other than statutorily excluded shares of common stock; or
|
•
|
on or subsequent to the date of the transaction, the business combination is approved by SpringBig’s Board of Directors and
authorized at a meeting of SpringBig’s shareholders, and not by written consent, by an affirmative vote of at least two-thirds of the outstanding voting stock not owned by the interested shareholder.
|
•
|
purchases by a broker-dealer as principal and resale by such broker-dealer for its own account pursuant to this prospectus;
|
•
|
ordinary brokerage transactions and transactions in which the broker solicits purchasers;
|
•
|
block trades in which the broker-dealer so engaged will attempt to sell the shares as agent but may position and resell a
portion of the block as principal to facilitate the transaction;
|
•
|
an over-the-counter distribution in accordance with the rules of the Nasdaq Stock Market LLC;
|
•
|
through trading plans entered into by a Holder pursuant to Rule 10b5-1 under the Exchange Act, that are in place at the time
of an offering pursuant to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of their securities on the basis of parameters described in such trading plans;
|
•
|
to or through underwriters or broker-dealers;
|
•
|
in privately negotiated transactions;
|
•
|
in options transactions;
|
•
|
through a combination of any of the above methods of sale; or
|
•
|
any other method permitted pursuant to applicable law.
|
•
|
1% of the total number of Common Shares then outstanding; or
|
•
|
the average weekly reported trading volume of such securities during the four calendar weeks preceding the filing of a notice
on Form 144 with respect to the sale.
|
Unaudited Financial Statements
|
| |
|
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
|
| |
|
Audited Financial Statements
|
| |
|
| | ||
| | ||
| | ||
| | ||
| | ||
| |
Audited Financial Statements
|
| |
|
| | ||
Financial Statements:
|
| |
|
| | ||
| | ||
| | ||
| | ||
| |
|
| |
June 30,
2022
|
| |
December, 31,
2021*
|
|
| |
(unaudited)
|
| |
|
|
| |
(In thousands except share data)
|
|||
ASSETS
|
| |
|
| |
|
Assets
|
| |
|
| |
|
Current assets:
|
| |
|
| |
|
Cash and cash equivalents
|
| |
$
|
| |
$
|
Accounts receivable, net
|
| |
|
| |
|
Contract assets
|
| |
|
| |
|
Prepaid expenses and other current assets
|
| |
|
| |
|
Total current assets
|
| |
|
| |
|
Property and equipment, net
|
| |
|
| |
|
Convertible note receivable
|
| |
|
| |
|
Total assets
|
| |
$
|
| |
$
|
|
| |
|
| |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
| |
|
| |
|
Liabilities
|
| |
|
| |
|
Current liabilities:
|
| |
|
| |
|
Accounts payable
|
| |
$
|
| |
$
|
Accrued expense and other current liabilities
|
| |
|
| |
|
Deferred revenue
|
| |
|
| |
|
Total current liabilities
|
| |
|
| |
|
Senior secured convertible notes, at estimated fair value
|
| |
|
| |
|
Warrant liabilities, at estimated fair value
|
| |
|
| |
|
Total liabilities
|
| |
|
| |
|
|
| |
|
| |
|
Commitments and Contingencies
|
| |
|
| |
|
Stockholders’ Equity
|
| |
|
| |
|
Common stock (par value $
|
| |
$
|
| |
$
|
Additional paid-in-capital
|
| |
|
| |
|
Accumulated deficit
|
| |
(
|
| |
(
|
Total stockholders’ equity
|
| |
|
| |
|
Total liabilities and stockholders’ equity
|
| |
$
|
| |
$
|
*
|
|
|
| |
Three Months Ended June 30,
|
| |
Six Months Ended June 30,
|
||||||
|
| |
2022
|
| |
2021
|
| |
2022
|
| |
2021
|
|
| |
(In thousands, except share and per share data)
|
|||||||||
Revenues
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
Cost of revenues
|
| |
|
| |
|
| |
|
| |
|
Gross profit
|
| |
|
| |
|
| |
|
| |
|
Operating expenses
|
| |
|
| |
|
| |
|
| |
|
Selling, servicing and marketing
|
| |
|
| |
|
| |
|
| |
|
Technology and software development
|
| |
|
| |
|
| |
|
| |
|
General and administrative
|
| |
|
| |
|
| |
|
| |
|
Total operating expenses
|
| |
|
| |
|
| |
|
| |
|
Loss from operations
|
| |
(
|
| |
(
|
| |
(
|
| |
(
|
Interest income
|
| |
|
| |
|
| |
|
| |
|
Interest expense
|
| |
(
|
| |
|
| |
(
|
| |
|
Change in fair value of senior secured convertible note
|
| |
|
| |
|
| |
|
| |
|
Change in fair value of warrants
|
| |
|
| |
|
| |
|
| |
|
Loss before income tax
|
| |
(
|
| |
(
|
| |
(
|
| |
(
|
Income tax expense
|
| |
|
| |
|
| |
|
| |
|
Net loss
|
| |
$(
|
| |
$(
|
| |
$(
|
| |
$(
|
Net loss per common share:
|
| |
|
| |
|
| |
|
| |
|
Basic and diluted
|
| |
$(
|
| |
$(
|
| |
$(
|
| |
$(
|
Weighted-average common shares outstanding
|
| |
|
| |
|
| |
|
| |
|
Basic and diluted
|
| |
|
| |
|
| |
|
| |
|
|
| |
Common Stock
Shares
|
| |
Amount
|
| |
Additional
Paid-in-
Capital
|
| |
Accumulated
Deficit
|
| |
Total
|
|
| |
(In thousands, except share data)
|
||||||||||||
Balance at December 31, 2021
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| |
$
|
Stock-based compensation
|
| |
—
|
| |
—
|
| |
|
| |
—
|
| |
|
Exercise of stock options
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
Recapitalization
|
| |
|
| |
|
| |
|
| |
—
|
| |
|
Net loss
|
| |
—
|
| |
—
|
| |
—
|
| |
(
|
| |
(
|
Balance at June 30, 2022
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| |
$
|
|
| |
Common Stock
Shares
|
| |
Amount
|
| |
Additional
Paid-in-
Capital
|
| |
Accumulated
Deficit
|
| |
Total
|
|
| |
(In thousands, except share data)
|
||||||||||||
Balance at December 31, 2020
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| |
$
|
Stock-based compensation
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
Issue of common stock
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
Net loss
|
| |
—
|
| |
—
|
| |
—
|
| |
$(
|
| |
(
|
Balance at June 30, 2021
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| |
$
|
|
| |
Three Months Ended June 30,
|
|||
|
| |
2022
|
| |
2021
|
|
| |
(In thousands)
|
|||
Cash flows from operating activities:
|
| |
|
| |
|
Net loss
|
| |
$(
|
| |
$(
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
| |
|
| |
|
Depreciation and amortization
|
| |
|
| |
|
Stock-based compensation expense
|
| |
|
| |
|
Change in fair value of convertible notes
|
| |
(
|
| |
|
Change in fair value of warrants
|
| |
(
|
| |
|
Changes in operating assets and liabilities:
|
| |
|
| |
|
Accounts receivable
|
| |
(
|
| |
(
|
Prepaid expenses and other current assets
|
| |
(
|
| |
(
|
Contract assets
|
| |
(
|
| |
(
|
Accounts payable and other liabilities
|
| |
|
| |
|
Contract liabilities
|
| |
(
|
| |
|
Net cash used in operating activities
|
| |
(
|
| |
(
|
|
| |
|
| |
|
Cash flows from investing activities:
|
| |
|
| |
|
Purchase of convertible note
|
| |
(
|
| |
|
Purchases of property and equipment
|
| |
(
|
| |
(
|
Net cash used in investing activities
|
| |
(
|
| |
(
|
|
| |
|
| |
|
Cash flows from financing activities:
|
| |
|
| |
|
Business combination, net of issuing cost
|
| |
|
| |
|
Proceeds from exercise of stock options, net
|
| |
|
| |
|
Net cash provided by financing activities
|
| |
|
| |
|
|
| |
|
| |
|
Net increase (decrease) in cash and cash equivalents
|
| |
|
| |
(
|
Cash and cash equivalents at beginning of period
|
| |
|
| |
|
Cash and cash equivalents at end of period
|
| |
$
|
| |
$
|
|
| |
|
| |
|
Supplemental disclosure of non-cash financing activities
|
| |
|
| |
|
Conversion of convertible note and outstanding interest into common stock
|
| |
$
|
| |
$
|
Warrant assumed in business combination at estimate fair value
|
| |
$
|
| |
$
|
|
| |
Six Months Ended June 30,
|
|||
|
| |
2022
|
| |
2021
|
|
| |
(In thousands)
|
|||
Cash flows from operating activities:
|
| |
|
| |
|
Net loss
|
| |
$(
|
| |
$(
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
| |
|
| |
|
Depreciation and amortization
|
| |
|
| |
|
Stock-based compensation expense
|
| |
|
| |
|
Change in fair value of convertible notes
|
| |
(
|
| |
|
Change in fair value of warrants
|
| |
(
|
| |
|
Changes in operating assets and liabilities:
|
| |
|
| |
|
Accounts receivable
|
| |
(
|
| |
(
|
Prepaid expenses and other current assets
|
| |
(
|
| |
(
|
Contract assets
|
| |
|
| |
(
|
Accounts payable and other liabilities
|
| |
|
| |
|
Contract liabilities
|
| |
(
|
| |
|
Net cash used in operating activities
|
| |
(
|
| |
(
|
|
| |
|
| |
|
Cash flows from investing activities:
|
| |
|
| |
|
Business combination, net of cash acquired
|
| |
|
| |
(
|
Purchase of convertible note
|
| |
(
|
| |
|
Purchases of property and equipment
|
| |
(
|
| |
(
|
Net cash used in investing activities
|
| |
(
|
| |
(
|
|
| |
|
| |
|
Cash flows from financing activities:
|
| |
|
| |
|
Business combination, net of issuing cost
|
| |
|
| |
|
Proceeds from convertible notes
|
| |
|
| |
|
Proceeds from exercise of stock options, net
|
| |
|
| |
|
Net cash provided by financing activities
|
| |
|
| |
|
Net increase (decrease) in cash and cash equivalents
|
| |
|
| |
(
|
Cash and cash equivalents at beginning of period
|
| |
|
| |
|
Cash and cash equivalents at end of period
|
| |
$
|
| |
$
|
|
| |
|
| |
|
Supplemental disclosure of non-cash financing activities
|
| |
|
| |
|
Issue of common stock for business combination
|
| |
$
|
| |
$
|
Indemnity holdback for business combination
|
| |
$
|
| |
$
|
Conversion of convertible note and outstanding interest into common stock
|
| |
$
|
| |
$
|
Warrant assumed in business combination at estimate fair value
|
| |
$
|
| |
$
|
|
| |
June 30,
2022
|
| |
December 31,
2021
|
Accounts receivable
|
| |
$
|
| |
$
|
Unbilled receivables
|
| |
|
| |
|
|
| |
|
| |
|
Less allowance for doubtful accounts
|
| |
(
|
| |
(
|
Accounts receivable, net
|
| |
$
|
| |
$
|
|
| |
June 30,
2022
|
| |
December 31,
2021
|
Prepaid insurance
|
| |
$
|
| |
$
|
Other prepaid expenses
|
| |
|
| |
|
Deposits
|
| |
|
| |
|
|
| |
$
|
| |
$
|
|
| |
June 30,
2022
|
| |
December 31,
2021
|
Computer equipment
|
| |
$
|
| |
$
|
Data warehouse
|
| |
|
| |
|
Software
|
| |
|
| |
|
|
| |
|
| |
|
Less accumulated depreciation and amortization
|
| |
(
|
| |
(
|
Property and Equipment
|
| |
$
|
| |
$
|
|
| |
June 30,
2022
|
| |
December 31,
2021
|
Accrued wages, commission and bonus
|
| |
$
|
| |
$
|
Accrued expenses
|
| |
|
| |
|
Other liabilities
|
| |
|
| |
|
|
| |
|
| |
|
Related party payable
|
| |
|
| |
|
|
| |
$
|
| |
$
|
Amount available after paying TCAC redeeming stockholders
|
| |
$
|
Proceeds from convertible notes
|
| |
|
Proceeds from PIPE Financing
|
| |
|
TCAC operating account
|
| |
|
Gross proceeds available at closing
|
| |
|
Expenses paid at closing
|
| |
(
|
Net cash to Legacy SpringBig at closing
|
| |
$
|
Post closing expense (cash paid or accrued for expenses by Legacy SpringBig)
|
| |
(
|
Net cash after closing
|
| |
$
|
TCAC non-redeeming shareholders
|
| |
|
PIPE Investors
|
| |
|
TCAC sponsor shareholders
|
| |
|
Legacy SpringBig shareholders
|
| |
|
Issued and outstanding
|
| |
|
|
| |
June 30, 2021
|
Fair value of shares
|
| |
$
|
Less: Post combination cost - restricted shares
|
| |
(
|
Fair value of net shares
|
| |
|
Cash consideration
|
| |
|
Indemnity holdback
|
| |
|
Fair value of purchase consideration
|
| |
$
|
|
| |
|
Assets assumed
|
| |
$
|
Goodwill
|
| |
|
Intangibles (Software)
|
| |
|
Fair value of assets
|
| |
$
|
|
| |
Three Months Ended June 30,
|
| |
Six Months Ended June 30,
|
||||||
|
| |
2022
|
| |
2021
|
| |
2022
|
| |
2021
|
Revenue
|
| |
|
| |
|
| |
|
| |
|
Brand revenue
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
Retail revenue
|
| |
|
| |
|
| |
|
| |
|
Total Revenue
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
|
| |
Three Months Ended June 30,
|
| |
Six Months Ended June 30,
|
||||||
|
| |
2022
|
| |
2021
|
| |
2022
|
| |
2021
|
Retail revenue
|
| |
|
| |
|
| |
|
| |
|
United States
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
Canada
|
| |
|
| |
|
| |
|
| |
|
Brand revenue
|
| |
|
| |
|
| |
|
| |
|
United States
|
| |
|
| |
|
| |
|
| |
|
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
|
| |
June 30,
2022
|
| |
December 31,
2021
|
Contract assets consisted of the following as of:
|
| |
|
| |
|
Deferred sales commissions
|
| |
$
|
| |
$
|
|
| |
June 30,
2022
|
| |
December 31,
2021
|
Contract liabilities consisted of the following as of:
|
| |
|
| |
|
Deferred revenue retail
|
| |
$
|
| |
$
|
Deferred set-up revenues
|
| |
|
| |
|
Deferred brands
|
| |
|
| |
|
Contract liabilities
|
| |
$
|
| |
$
|
|
| |
June 30,
2022
|
| |
December 31,
2021
|
The movement in the contract liabilities during each period comprised the
following:
|
| |
|
| |
|
Contract liabilities at start of the period
|
| |
$
|
| |
$
|
Amounts invoiced during the period
|
| |
|
| |
|
Less revenue recognized during the period
|
| |
(
|
| |
(
|
Contract liabilities at end of the period
|
| |
$
|
| |
$
|
|
| |
Options Outstanding
|
| |
Options Vested and Exercisable
|
|||||||||
Fixed Options
|
| |
Number of
Options
|
| |
Weighted
Average
Exercise Price
(Per Share)
|
| |
Number of
Options
|
| |
Weighted
Average
Remaining
Contractual
Life (Years)
|
| |
Weighted
Average
Exercise
Price (Per
Share)
|
Outstanding Balance, January 1, 2022
|
| |
|
| |
$
|
| |
|
| |
|
| |
$
|
Options granted
|
| |
|
| |
|
| |
|
| |
|
| |
|
Options exercised
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Options forfeited
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Options cancelled
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Outstanding Balance, June 30, 2022
|
| |
|
| |
|
| |
|
| |
|
| |
|
Conversion ratio
|
| |
|
| |
|
| |
|
| |
|
| |
|
SpringBig Holdings options
|
| |
|
| |
|
| |
|
| |
—
|
| |
—
|
Level 1:
|
Valuation is based on unadjusted quoted prices in active markets for
identical assets and liabilities that are accessible at the reporting date. Because valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a
significant degree of judgment.
|
Level 2:
|
Valuation is determined from pricing inputs that are other than quoted
prices in active markets that are either directly or indirectly observable as of the reporting date. Observable inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar
assets or liabilities in markets that are not active, and interest rates and yield curves that are observable at commonly quoted intervals.
|
Level 3:
|
Valuation is based on inputs that are both significant to the fair
value measurement and unobservable. Level 3 inputs include situations where there is little, if any, market activity for the financial instrument. The inputs into the determination of fair value generally require significant
management judgment or estimation. .
|
|
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total Fair
Value
|
Liabilities:
|
| |
|
| |
|
| |
|
| |
|
Senior secured convertible note
|
| |
$
|
| |
$—
|
| |
$
|
| |
$
|
Private warrants
|
| |
—
|
| |
|
| |
—
|
| |
|
Public warrants
|
| |
|
| |
—
|
| |
—
|
| |
|
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
Warrants
|
| |
|
Balance, January 1, 2022
|
| |
$
|
Assumed in business combination
|
| |
|
Change in fair value
|
| |
(
|
Balance, June 30, 2022
|
| |
$
|
Changes in fair value included in earnings for the period relating to
liabilities held at June 30, 2022
|
| |
$(
|
Senior Secured Convertible Note
|
| |
|
Balance, January 1, 2022
|
| |
$
|
Issued in business combination
|
| |
|
Valuation adjustment at business combination
|
| |
(
|
Change in fair value
|
| |
(
|
Balance, June 30, 2022
|
| |
$
|
Changes in fair value included in earnings for the period relating to
liabilities held at June 30, 2022
|
| |
$(
|
|
| |
Legacy SpringBig
|
| |
Conversion Rate
|
| |
SpringBig
|
Series B Preferred
|
| |
|
| |
|
| |
|
Series A Preferred
|
| |
|
| |
|
| |
|
Series Seed Preferred
|
| |
|
| |
|
| |
|
Common Stock
|
| |
|
| |
|
| |
|
|
| |
|
| |
|
| |
|
a.
|
|
b.
|
|
c.
|
|
|
| |
Three Months Ended June 30,
|
| |
Six Months Ended June 30,
|
||||||
|
| |
2022
|
| |
2021
|
| |
2022
|
| |
2021
|
Loss per share:
|
| |
|
| |
|
| |
|
| |
|
Numerator:
|
| |
|
| |
|
| |
|
| |
|
Net loss
|
| |
$(
|
| |
$(
|
| |
$(
|
| |
$(
|
Denominator
|
| |
|
| |
|
| |
|
| |
|
Weighted-average common shares outstanding
|
| |
|
| |
|
| |
|
| |
|
Basic and diluted
|
| |
|
| |
|
| |
|
| |
|
Net loss per common share
|
| |
|
| |
|
| |
|
| |
|
Basic
|
| |
$(
|
| |
$(
|
| |
$(
|
| |
$(
|
|
| |
2022
|
| |
2021
|
Shares unvested and subject to exercise of stock options
|
| |
|
| |
|
Shares subject to outstanding common stock options
|
| |
|
| |
|
Shares subject to convertible notes stock conversion
|
| |
|
| |
|
Shares subject to warrants stock conversion
|
| |
|
| |
|
|
| |
2021
|
| |
2020
|
|
| |
(In thousands except share data)
|
|||
ASSETS
|
| |
|
| |
|
Assets
|
| |
|
| |
|
Current assets:
|
| |
|
| |
|
Cash and cash equivalents
|
| |
$
|
| |
$
|
Accounts receivable, net
|
| |
|
| |
|
Related party receivable
|
| |
|
| |
|
Contract assets
|
| |
|
| |
|
Prepaid expenses and other current assets
|
| |
|
| |
|
Total current assets
|
| |
|
| |
|
Property and equipment, net
|
| |
|
| |
|
Deposits
|
| |
|
| |
|
Total assets
|
| |
$
|
| |
$
|
|
| |
|
| |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
| |
|
| |
|
Liabilities
|
| |
|
| |
|
Current liabilities:
|
| |
|
| |
|
Accounts payable
|
| |
$
|
| |
$
|
Related party payable
|
| |
|
| |
|
Accrued wages and commissions
|
| |
|
| |
|
Accrued expenses
|
| |
|
| |
|
Other liabilities
|
| |
|
| |
|
PPP loan payable, current portion
|
| |
|
| |
|
Contract liabilities
|
| |
|
| |
|
Total current liabilities
|
| |
|
| |
|
PPP loan payable, net of current portion
|
| |
|
| |
|
Total liabilities
|
| |
$
|
| |
$
|
|
| |
|
| |
|
Commitments and Contingencies
|
| |
|
| |
|
|
| |
|
| |
|
Stockholders’ Equity:
|
| |
|
| |
|
Series B Preferred (par value $
|
| |
$
|
| |
$
|
Series A Preferred (par value $
|
| |
|
| |
|
Series Seed Preferred (par value $
|
| |
|
| |
|
Common stock (par value $
|
| |
|
| |
|
Additional paid-in-capital
|
| |
|
| |
|
Accumulated deficit
|
| |
(
|
| |
(
|
Total stockholders’ equity
|
| |
|
| |
|
Total liabilities and stockholders’ equity
|
| |
$
|
| |
$
|
|
| |
2021
|
| |
2020
|
|
| |
(In thousands, except share
and per share data)
|
|||
Revenues
|
| |
$
|
| |
$
|
Cost of revenues
|
| |
|
| |
|
Gross Profit
|
| |
|
| |
|
Operating expenses
|
| |
|
| |
|
Selling, servicing and marketing
|
| |
|
| |
|
Technology and software development
|
| |
|
| |
|
General and administrative
|
| |
|
| |
|
|
| |
|
| |
|
|
| |
|
| |
|
Loss from operations
|
| |
(
|
| |
(
|
Interest income
|
| |
|
| |
|
Forgiveness of PPP loan
|
| |
|
| |
|
Loss before provision for income taxes
|
| |
(
|
| |
(
|
Provision for income taxes
|
| |
|
| |
|
Net loss
|
| |
$(
|
| |
$(
|
Net loss per common share:
|
| |
|
| |
|
Basic and diluted
|
| |
$(
|
| |
$(
|
Weighted-average common shares outstanding - basic and diluted
|
| |
|
| |
|
|
| |
Series B Preferred
|
| |
Series A Preferred
|
| |
Series Seed Preferred
|
| |
Common Stock
|
| |
Additional
Paid-in Capital
|
| |
Accumulated
Deficit
|
| |
Total
|
||||||||||||
|
| |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||
Balance - January 1, 2020
|
| |
|
| |
$
|
| |
|
| |
$
|
| |
|
| |
$
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| |
$
|
Stock-based compensation
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Exercise of stock options
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Redemption of common stock
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
(
|
| |
(
|
| |
(
|
| |
|
| |
(
|
Issuance of Series B preferred stock
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Net loss
|
| |
—
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
| |
|
| |
(
|
| |
(
|
Balance - December 31, 2020
|
| |
|
| |
$
|
| |
|
| |
$
|
| |
|
| |
$
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| | $ |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Stock-based compensation
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Exercise of stock options
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Issuance of common stock
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Net loss
|
| |
—
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
| |
|
| |
(
|
| |
(
|
Balance - December 31, 2021
|
| |
|
| |
$
|
| |
|
| |
$
|
| |
|
| |
$
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| |
$
|
|
| |
2021
|
| |
2020
|
|
| |
(In thousands)
|
|||
Cash flows from operating activities:
|
| |
|
| |
|
Net loss
|
| |
$(
|
| |
$(
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
| |
|
| |
|
Depreciation and amortization
|
| |
|
| |
|
Stock-based compensation expense
|
| |
|
| |
|
Forgiveness of PPP loan
|
| |
(
|
| |
|
Changes in operating assets and liabilities:
|
| |
|
| |
|
Accounts receivable
|
| |
(
|
| |
(
|
Related party receivable
|
| |
|
| |
(
|
Prepaid expenses and other current assets
|
| |
(
|
| |
(
|
Contract assets
|
| |
(
|
| |
(
|
Deposits and other assets
|
| |
(
|
| |
(
|
Accounts payable and other liabilities
|
| |
|
| |
|
Related party payable
|
| |
(
|
| |
|
Contract liabilities
|
| |
(
|
| |
|
Net cash used in operating activities
|
| |
(
|
| |
(
|
Cash flows from investing activities:
|
| |
|
| |
|
Business combination, net of cash acquired
|
| |
(
|
| |
|
Purchases of property and equipment
|
| |
(
|
| |
(
|
Net cash used in investing activities
|
| |
(
|
| |
(
|
Cash flows from financing activities:
|
| |
|
| |
|
Proceeds from PPP loan
|
| |
|
| |
|
Proceeds from issuance of common stock
|
| |
|
| |
|
Repurchase of common stock
|
| |
|
| |
(
|
Proceeds from exercise of stock options, net
|
| |
|
| |
|
Net cash provided by financing activities
|
| |
|
| |
|
Net (decrease) increase in cash and cash equivalents
|
| |
(
|
| |
|
Cash and cash equivalents at beginning of year
|
| |
|
| |
|
Cash and cash equivalents at end of year
|
| |
$
|
| |
$
|
|
| |
|
| |
|
Supplemental disclosure of non-cash financing activities
|
| |
|
| |
|
Issue of common stock for business combination
|
| |
$
|
| |
$
|
Indemnity holdback for business combination
|
| |
$
|
| |
$
|
|
| |
December 31,
|
|||
|
| |
2021
|
| |
2020
|
Accounts receivable
|
| |
$
|
| |
$
|
Unbilled receivables
|
| |
|
| |
|
|
| |
|
| |
|
Less allowance for doubtful accounts
|
| |
(
|
| |
(
|
Accounts receivable, net
|
| |
$
|
| |
$
|
|
| |
December 31,
|
|||
|
| |
2021
|
| |
2020
|
Computer equipment
|
| |
$
|
| |
$
|
Data warehouse
|
| |
|
| |
|
Software
|
| |
|
| |
|
|
| |
|
| |
|
Less accumulated depreciation and amortization
|
| |
(
|
| |
(
|
Property and Equipment
|
| |
$
|
| |
$
|
|
| |
December 31
|
|||
|
| |
2021
|
| |
2020
|
Revenue
|
| |
|
| |
|
Brand revenue
|
| |
$
|
| |
$
|
Retail revenue
|
| |
|
| |
|
Total Revenue
|
| |
$
|
| |
$
|
|
| |
December 31
|
|||
|
| |
2021
|
| |
2020
|
Retail revenue
|
| |
|
| |
|
United States
|
| |
$
|
| |
$
|
Canada
|
| |
|
| |
|
Brand revenue
|
| |
|
| |
|
United States
|
| |
|
| |
|
|
| |
$
|
| |
$
|
|
| |
December 31
|
|||
|
| |
2021
|
| |
2020
|
Deferred sales commissions
|
| |
$
|
| |
$
|
|
| |
December 31
|
|||
|
| |
2021
|
| |
2020
|
Deferred revenue retail
|
| |
$
|
| |
$
|
Deferred set-up revenues
|
| |
|
| |
|
Deferred brands
|
| |
|
| |
|
Contract liabilities
|
| |
$
|
| |
$
|
|
| |
December 31
|
|||
|
| |
2021
|
| |
2020
|
Contract liabilities at start of the year
|
| |
$
|
| |
$
|
Amounts invoiced during the year
|
| |
|
| |
|
Less revenue recognized during the year
|
| |
(
|
| |
(
|
Contract liabilities at end of the year
|
| |
$
|
| |
$
|
|
| |
December 31, 2021
|
Fair value of shares
|
| |
$
|
Less: Post combination cost - restricted stocks
|
| |
(
|
Fair value of net shares
|
| |
|
Cash consideration
|
| |
|
Indemnity holdback
|
| |
|
Fair value of purchase consideration
|
| |
|
Cash
|
| |
$
|
Goodwill
|
| |
|
Intangibles (Software)
|
| |
|
Fair value of assets
|
| |
$
|
|
| |
Options Outstanding
|
| |
Options Vested and Exercisable
|
|||||||||
Fixed Options
|
| |
Number of
Options
|
| |
Weighted
Average
Exercise
Price (Per
Share)
|
| |
Number
of
Options
|
| |
Weighted
Average
Remaining
Contractual
Life (Years)
|
| |
Weighted
Average
Exercise
Price (Per
Share)
|
Outstanding Balance, January 1, 2020
|
| |
|
| |
$
|
| |
|
| |
|
| |
$
|
Options granted
|
| |
|
| |
$
|
| |
|
| |
|
| |
|
Options exercised
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Options forfeited
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Options cancelled
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Outstanding Balance, December 31, 2020
|
| |
|
| |
$
|
| |
|
| |
|
| |
$
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
Options granted
|
| |
|
| |
$
|
| |
|
| |
|
| |
|
Options exercised
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Options forfeited
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Options cancelled
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Outstanding Balance, December 31, 2021
|
| |
|
| |
$
|
| |
|
| |
|
| |
$
|
|
| |
Options Outstanding
|
| |
Options Vested and Exercisable
|
||||||
|
| |
(In thousands except share data)
|
| |
(In thousands except share data)
|
||||||
Fixed Options
|
| |
Number of
Options
|
| |
Aggregate Intrinsic
Value
|
| |
Number of
Options
|
| |
Aggregate Intrinsic
Value
|
January 1, 2020
|
| |
|
| |
$
|
| |
|
| |
$
|
December 31, 2020
|
| |
|
| |
$
|
| |
|
| |
$
|
December 31, 2021
|
| |
|
| |
$
|
| |
|
| |
$
|
|
| |
2021
|
| |
2020
|
Risk-free rate
|
| |
|
| |
|
Expected life (years)
|
| |
|
| |
|
Expected volatility
|
| |
|
| |
|
Expected dividend yield
|
| |
|
| |
|
December 31
|
| |
Amount
|
2022
|
| |
$
|
2023
|
| |
|
2024
|
| |
|
|
| |
$
|
|
| |
December 31
|
|||
|
| |
2021
|
| |
2020
|
Loss per share:
|
| |
|
| |
|
Numerator:
|
| |
|
| |
|
Net loss
|
| |
$(
|
| |
$(
|
|
| |
|
| |
|
Denominator
|
| |
|
| |
|
Weighted-average common shares outstanding - basic and diluted
|
| |
|
| |
|
________ | ________ | |||||
Basic and diluted loss per common share
|
| |
$(
|
| |
$(
|
|
| |
December 31
|
|||
|
| |
2021
|
| |
2020
|
Shares subject to Series A Preferred Stock Conversion
|
| |
|
| |
|
Shares subject to Series B Preferred Stock Conversion
|
| |
|
| |
|
Shares subject to Seed Preferred Stock Conversion
|
| |
|
| |
|
Shares vested and subject to exercise of stock options
|
| |
|
| |
|
Shares unvested and subject to exercise of stock options
|
| |
|
| |
|
|
| |
December 31
|
|||
|
| |
2021
|
| |
2020
|
Provision (benefit) for income taxes
|
| |
|
| |
|
Current
|
| |||||
Federal
|
| |
$
|
| |
$
|
State
|
| |
|
| |
|
International
|
| |
|
| |
|
|
| |
$
|
| |
$
|
|
| |
December 31
|
|||
|
| |
2021
|
| |
2020
|
Loss from operations
|
| |
|
| |
|
U.S.
|
| |
(
|
| |
(
|
Foreign
|
| |
(
|
| |
|
|
| |
$(
|
| |
$(
|
|
| |
December 31, 2021
|
| |
December 31, 2020
|
||||||
|
| |
Amount
|
| |
Rate
|
| |
Amount
|
| |
Rate
|
U.S. federal income tax provision (benefit) at statutory rate
|
| |
$(
|
| |
|
| |
$(
|
| |
|
Increase (decrease) in taxes resulting from:
|
| |
|
| |
|
| |
|
| |
|
State income tax expense
|
| |
|
| |
|
| |
|
| |
|
Foreign income and losses taxed at different rates
|
| |
(
|
| |
|
| |
|
| |
|
Change in valuation allowance
|
| |
|
| |
(
|
| |
|
| |
(
|
Paycheck protection program forgiveness
|
| |
(
|
| |
|
| |
|
| |
|
Non-deductible or non-taxable items
|
| |
(
|
| |
|
| |
(
|
| |
|
Effect of income tax rate changes on deferred items
|
| |
(
|
| |
|
| |
|
| |
|
Provision (benefit) for income taxes
|
| |
$
|
| |
|
| |
$
|
| |
|
|
| |
December 31
|
|||
|
| |
2021
|
| |
2020
|
Deferred tax assets:
|
| |
|
| |
|
Accrued expenses and other liabilities
|
| |
|
| |
|
Property and equipment, net
|
| |
|
| |
|
Net operating loss
|
| |
|
| |
|
Stock-based compensation
|
| |
|
| |
|
Total gross deferred tax assets
|
| |
|
| |
|
Less: valuation allowance
|
| |
(
|
| |
(
|
Total deferred tax assets
|
| |
|
| |
|
Deferred tax liabilities:
|
| |
|
| |
|
Prepaid expenses and other assets
|
| |
(
|
| |
|
Property and equipment, net
|
| |
(
|
| |
|
Total deferred tax liabilities
|
| |
(
|
| |
|
Net deferred income tax asset (liability)
|
| |
|
| |
|
|
| |
December 31,
|
|||
|
| |
2021
|
| |
2020
|
ASSETS
|
| |
|
| |
|
Current assets
|
| |
|
| |
|
Cash
|
| |
$621,472
|
| |
$185,752
|
Prepaid expenses
|
| |
259,939
|
| |
—
|
Total Current Assets
|
| |
881,411
|
| |
185,752
|
|
| |
|
| |
|
Deferred offering costs
|
| |
—
|
| |
417,083
|
Investments held in Trust Account
|
| |
200,035,810
|
| |
—
|
TOTAL ASSETS
|
| |
$200,917,221
|
| |
$602,835
|
|
| |
|
| |
|
LIABILITIES, CLASS A ORDINARY SHARES
SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ EQUITY (DEFICIT)
|
| |
|
| |
|
Current liabilities
|
| |
|
| |
|
Accounts payable and accrued expenses
|
| |
$1,555,405
|
| |
$—
|
Accrued offering costs
|
| |
108,000
|
| |
332,899
|
Promissory note – related party
|
| |
—
|
| |
250,000
|
Total Current Liabilities
|
| |
1,663,405
|
| |
582,899
|
|
| |
|
| |
|
Warrant Liabilities
|
| |
9,440,000
|
| |
—
|
Deferred underwriting fee payable
|
| |
7,000,000
|
| |
—
|
Total Liabilities
|
| |
18,103,405
|
| |
582,899
|
|
| |
|
| |
|
Commitments and Contingencies
|
| |
|
| |
|
Class A ordinary shares subject to possible redemption
20,000,000 and no shares at $10.00 per share at December 31, 2021 and 2020, respectively
|
| |
200,000,000
|
| |
—
|
|
| |
|
| |
|
Shareholders’ Equity (Deficit)
|
| |
|
| |
|
Preference shares, $0.0001 par value; 1,000,000 shares
authorized; none issued or outstanding
|
| |
—
|
| |
—
|
Class A ordinary shares, $0.0001 par value; 200,000,000
shares authorized -0- shares issued and outstanding at December 31, 2021 and 2020
|
| |
—
|
| |
—
|
Class B ordinary shares, $0.0001 par value; 20,000,000
shares authorized; 5,000,000 and 5,031,250 (1) shares issued and outstanding at December 31, 2021 and 2020, respectively
|
| |
500
|
| |
503
|
Additional paid-in capital
|
| |
—
|
| |
24,497
|
Accumulated deficit
|
| |
(17,186,684)
|
| |
(5,064)
|
Total Shareholder’s Equity (Deficit)
|
| |
(17,186,184)
|
| |
19,936
|
TOTAL LIABILITIES, CLASS A ORDINARY
SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ EQUITY (DEFICIT)
|
| |
$200,917,221
|
| |
$602,835
|
(1)
|
Excludes an aggregate of up to 656,250 shares that are subject to forfeiture if the over-allotment option is not exercised in
full or in part by the underwriters (see Note 5). On January 26, 2021, the Sponsor returned 1,437,500 Class B ordinary shares to the Company, which were canceled, and on February 11, 2021 the Company effected a share capitalization
pursuant to which an additional 718,750 Founder Shares were issued resulting in an aggregate of 5,031,250 Class B ordinary shares outstanding (see Note 5). All share and per-share amounts have been retroactively restated to reflect the
share cancellation.
|
|
| |
Year Ended
December 31,
2021
|
| |
Period from January 24,
2020 (Inception) through
December 31, 2020
|
Operating and formation costs
|
| |
$2,035,074
|
| |
$5,064
|
Loss from operations
|
| |
(2,035,074)
|
| |
(5,064)
|
|
| |
|
| |
|
Other income (expense):
|
| |
|
| |
|
Change in fair value of warrant liabilities
|
| |
12,960,000
|
| |
—
|
Transaction costs allocated to warrant liabilities
|
| |
(853,386)
|
| |
—
|
Compensation expense
|
| |
(2,400,000)
|
| |
—
|
Interest earned on investments held in Trust Account
|
| |
35,810
|
| |
—
|
Other income (expense), net
|
| |
9,742,424
|
| |
—
|
|
| |
|
| |
|
Net income (loss)
|
| |
$7,707,350
|
| |
$(5,064)
|
|
| |
|
| ||
Basic weighted average shares outstanding, Class A ordinary shares
|
| |
17,369,863
|
| |
—
|
|
| |
|
| |
|
Basic net income per share, Class A ordinary shares
|
| |
$0.35
|
| |
$—
|
|
| |
|
| |
|
Basic weighted average shares outstanding, Class B ordinary shares
|
| |
4,917,808
|
| |
4,375,000
|
|
| |
|
| |
|
Basic net income per share, Class B ordinary shares
|
| |
$0.35
|
| |
$—
|
|
| |
|
| |
|
Diluted weighted average shares outstanding, Class B ordinary shares
|
| |
5,000,000
|
| |
4,375,000
|
|
| |
|
| |
|
Diluted net income per share, Class B ordinary shares
|
| |
$0.34
|
| |
$—
|
|
| |
Class B Ordinary
Shares
|
| |
Additional
Paid-in
Capital
|
| |
Accumulated
Deficit
|
| |
Total
Shareholders’
Equity (Deficit)
|
|||
|
| |
Shares
|
| |
Amount
|
| ||||||||
Balance – January 24, 2020 (inception)
|
| |
—
|
| |
$—
|
| |
$—
|
| |
$—
|
| |
$—
|
|
| |
|
| |
|
| ||||||||
Issuance of Class B ordinary shares to Sponsor
|
| |
5,031,250
|
| |
503
|
| |
24,497
|
| |
—
|
| |
25,000
|
|
| |
|
| |
|
| ||||||||
Net loss
|
| |
—
|
| |
—
|
| |
—
|
| |
(5,064)
|
| |
(5,064)
|
|
| |
|
| |
|
| ||||||||
Balance – December 31, 2020
|
| |
5,031,250
|
| |
503
|
| |
24,497
|
| |
(5,064)
|
| |
19,936
|
|
| |
|
| |
|
| ||||||||
Forfeiture of Founder Shares
|
| |
(31,250)
|
| |
(3)
|
| |
—
|
| |
3
|
| |
—
|
|
| |
|
| |
|
| ||||||||
Accretion for Class A ordinary shares to redemption amount
|
| |
—
|
| |
—
|
| |
(24,497)
|
| |
(24,888,973)
|
| |
(24,913,470)
|
|
| |
|
| |
|
| ||||||||
Net income
|
| |
—
|
| |
—
|
| |
—
|
| |
7,707,350
|
| |
7,707,350
|
|
| |
|
| |
|
| ||||||||
Balance – December 31, 2021
|
| |
5,000,000
|
| |
$500
|
| |
$—
|
| |
$(17,186,684)
|
| |
$(17,186,184)
|
|
| |
Year Ended
December 31,
2021
|
| |
Period from January 24,
2020 (Inception) through
December 31, 2020
|
Cash Flows from Operating Activities:
|
| |
|
| |
|
Net income (loss)
|
| |
$7,707,350
|
| |
$(5,064)
|
Adjustments to reconcile net income (loss) to net cash
used in operating activities:
|
| |
|
| |
|
Formation cost paid by Sponsor in exchange for issuance of
founder shares
|
| |
—
|
| |
5,000
|
Interest earned on investments securities held in Trust Account
|
| |
(35,810)
|
| |
—
|
Change in fair value of warrants
|
| |
(12,960,000)
|
| |
—
|
Transaction costs allocated to warrants
|
| |
853,386
|
| |
—
|
Compensation expense
|
| |
2,400,000
|
| |
|
Changes in operating assets and liabilities:
|
| |
|
| |
|
Prepaid expenses and other current assets
|
| |
(259,939)
|
| |
—
|
Accounts payable and accrued expenses
|
| |
1,555,405
|
| |
—
|
Net cash used in operating activities
|
| |
(739,608)
|
| |
(64)
|
|
| |
|
| |
|
Cash Flows from Investing Activities:
|
| |
|
| |
|
Investment of cash in Trust Account
|
| |
(200,000,000)
|
| |
—
|
Net cash used in investing activities
|
| |
(200,000,000)
|
| |
—
|
|
| |
|
| |
|
Cash Flows from Financing Activities:
|
| |
|
| |
|
Proceeds from issuance of Class B ordinary shares to Sponsor
|
| |
196,000,000
|
| |
25,000
|
Proceeds from sale of Private Placements Warrants
|
| |
6,000,000
|
| |
—
|
Proceeds from promissory note – related party
|
| |
—
|
| |
210,000
|
Repayment of promissory note – related party
|
| |
(250,000)
|
| |
—
|
Payment of offering costs
|
| |
(574,672)
|
| |
(49,184)
|
Net cash provided by financing activities
|
| |
201,175,328
|
| |
185,816
|
|
| |
|
| |
|
Net Change in Cash
|
| |
435,720
|
| |
185,752
|
Cash – Beginning of period
|
| |
185,752
|
| |
—
|
Cash – End of period
|
| |
$621,472
|
| |
$185,752
|
|
| |
|
| |
|
Non-Cash investing and financing activities:
|
| |
|
| |
|
Offering costs included in accrued offering costs
|
| |
$108,000
|
| |
$332,899
|
Offering costs paid through promissory note
|
| |
$—
|
| |
$35,000
|
Deferred underwriting fee payable
|
| |
$7,000,000
|
| |
$—
|
Gross proceeds
|
| |
$200,000,000
|
Less:
|
| |
|
Proceeds allocated to Public Warrants
|
| |
(14,000,000)
|
Class A ordinary shares issuance costs
|
| |
(10,913,470)
|
Plus:
|
| |
|
Accretion of carrying value to redemption value
|
| |
24,913,470
|
Class A ordinary shares subject to possible redemption
|
| |
$200,000,000
|
|
| |
Year Ended
December 31,
2021
|
| |
Period from January 24,
2020 (Inception) through
December 31, 2020
|
||||||
|
| |
Class A
|
| |
Class B
|
| |
Class A
|
| |
Class B
|
Basic net income (loss) per ordinary share
|
| |
|
| |
|
| |
|
| |
|
Numerator:
|
| |
|
| |
|
| |
|
| |
|
Allocation of net income (loss), as adjusted
|
| |
$6,006,712
|
| |
$1,700,638
|
| |
$—
|
| |
$(5,064)
|
Denominator:
|
| |
|
| |
|
| |
|
| |
|
Basic weighted average shares outstanding
|
| |
17,369,863
|
| |
4,917,808
|
| |
—
|
| |
4,375,000
|
Basic net income per ordinary share
|
| |
$0.35
|
| |
$0.35
|
| |
$—
|
| |
$—
|
|
| |
|
| |
|
| |
|
| |
|
Diluted net income (loss) per ordinary share
|
| |
|
| |
|
| |
|
| |
|
Numerator:
|
| |
|
| |
|
| |
|
| |
|
Allocation of net income (loss), as adjusted
|
| |
$5,984,642
|
| |
$1,722,708
|
| |
$—
|
| |
$(5,064)
|
Denominator:
|
| |
|
| |
|
| |
|
| |
|
Diluted weighted average shares outstanding
|
| |
17,369,863
|
| |
5,000,000
|
| |
—
|
| |
4,375,000
|
Diluted net income per ordinary share
|
| |
$0.34
|
| |
$0.34
|
| |
$—
|
| |
$—
|
(a)
|
Upon the closing of any Financing (which is contemplated to fund and close concurrently with the closing of the Business
Combination), the Company shall pay to Cantor a non-refundable cash fee equal to 4% of the aggregate maximum gross proceeds received or receivable in connection with such Financing, including, without limitation, aggregate amounts
committed by investors to purchase securities, whether or not all securities are issued on the closing date of the Equity Financing.
|
(b)
|
In no event shall the aggregate amount of the fees payable to Cantor pursuant to this section 3 be less than $1,500,000.
|
•
|
in whole but not in part;
|
•
|
to each warrant holder; and
|
•
|
if, and only if, the last reported sale price of the Class A ordinary shares for any 20 trading days within a 30 trading day
period ending three business days before sending the notice of redemption to warrant holders (the “ Reference Value”) equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the
exercise price of a warrant as described under the heading “Description of Securities—Warrants—Public Shareholders’ Redeemable Warrants—Anti-dilution Adjustments”).
|
•
|
in whole but not in part;
|
•
|
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to
exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the “fair market value” of the Class A ordinary shares;
|
•
|
if, and only if, the Reference Value (as defined in the above adjacent to “Redemption of warrants when the price per Class A
ordinary share equals or exceeds $18.00”) equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of
Securities—Warrants—Public Shareholders’ Redeemable Warrants—Anti-dilution Adjustments”); and
|
•
|
if the Reference Value is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon
exercise or the exercise price of a warrant as described under the heading “Description of Securities—Warrants—Public Shareholders’ Redeemable Warrants—Anti-dilution Adjustments”) the private placement warrants must also be concurrently
called for redemption on the same terms as the outstanding public warrants, as described above.
|
Level 1:
|
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market
in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
|
Level 2:
|
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar
assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
|
Level 3:
|
Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or
liability.
|
Description
|
| |
Level
|
| |
December 31,
2021
|
| |
December 31,
2020
|
Assets:
|
| |
|
| |
|
| |
|
Investments held in Trust Account – U.S. Treasury
Securities Money Market Fund
|
| |
1
|
| |
$200,035,810
|
| |
$—
|
|
| |
|
| |
|
| |
|
Liabilities:
|
| |
|
| |
|
| |
|
Warrant Liability – Public Warrants
|
| |
1
|
| |
$5,900,000
|
| |
$—
|
Warrant Liability – Private Placement Warrants
|
| |
2
|
| |
$3,540,000
|
| |
$—
|
|
| |
At
February 17,
2021
(Initial
Measurement)
|
Stock price
|
| |
$10.00
|
Strike price
|
| |
$11.50
|
Term (in years)
|
| |
5.0
|
Volatility
|
| |
25.0%
|
Risk-free rate
|
| |
0.85%
|
Dividend yield
|
| |
0.0%
|
|
| |
Private
Placement
|
| |
Public
|
| |
Warrant
Liabilities
|
Fair value as of January 1, 2021
|
| |
$—
|
| |
$—
|
| |
$—
|
Initial measurement on February 17, 2021
|
| |
8,400,000
|
| |
14,000,000
|
| |
22,400,000
|
Change in fair value
|
| |
(1,500,000)
|
| |
(2,500,000)
|
| |
(4,000,000)
|
Fair value as of June 30, 2021
|
| |
$6,900,000
|
| |
$11,500,000
|
| |
$18,400,000
|
Transfers to Level 1
|
| |
—
|
| |
11,500,000
|
| |
11,500,000
|
Transfers to Level 2
|
| |
6,900,000
|
| |
—
|
| |
6,900,000
|
Fair value as of December 31, 2021
|
| |
$—
|
| |
$—
|
| |
$—
|
(a)
|
Upon the closing of any Financing (which is contemplated to fund and close concurrently with the closing of the Business
Combination), the Company shall pay to CF&CO a non-refundable cash fee equal to 4% of the aggregate maximum gross proceeds received or receivable in connection with such Financing, including, without limitation, aggregate amounts
committed by investors to purchase securities, whether or not all securities are issued on the closing date of the Equity Financing.
|
(b)
|
In no event shall the aggregate amount of the fees payable to CF&CO pursuant to this section 3 be less than $1,500,000.
|
(c)
|
The fees payable pursuant to this section 3 shall be in addition to any other fees that the Company may be required to pay
directly to any prospective investor to secure its financing commitment.
|
(d)
|
For the avoidance of doubt, if the structure of a Financing contemplates multiple issuances, financing availability that is
contingent upon the occurrence of some future event or any other delayed consideration structure, such Financing shall be considered a single Financing, and not multiple Financings, and all fees payable pursuant to this section 3 for
such Financing shall be payable in full on the closing date of such Financing.
|
(e)
|
All fees payable hereunder will be payable in U.S. dollars in immediately available funds to CF&CO for its own account,
or as directed by it, free and clear of and without deduction for any and all present or future applicable taxes, levies, imposts, deductions, charges or withholdings and all liabilities with respect thereto (with appropriate gross-up
for withholding taxes) and will not be subject to reduction by way of setoff or counterclaim. Once paid, no fee will be refundable under any circumstances.
|
Item 13.
|
Other Expenses of Issuance and Distribution.
|
|
| |
Amount
|
SEC registration fee
|
| |
$773.27
|
FINRA fee
|
| |
$8,000
|
Legal fees and expenses
|
| |
*
|
Accounting fees and expenses
|
| |
$*
|
Financial printing and miscellaneous expenses
|
| |
$*
|
Total
|
| |
$*
|
*
|
These fees are calculated based on the securities offered and the number of issuances and accordingly cannot be determined at
this time.
|
Item 14.
|
Indemnification of Directors and Officers.
|
Item 15.
|
Recent Sales of Unregistered Securities.
|
•
|
Tuatara’s sponsor purchased an aggregate of 6,000,000 private placement warrants for a purchase price of $1.00 per warrant in
a private placement that occurred simultaneously with the closing of the initial public offering. Each private placement warrant may be exercised for one Common Shares at a price of $11.50 per share, subject to adjustment. The private
placement warrants (including the shares issuable upon exercise of the private placement warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by it until 30 days after the completion of the initial
business combination.
|
•
|
On June 14, 2022, at the first closing under the Notes and Warrants Purchase Agreement, we issued and sold to the Investor
(i) a Note in the principal amount of $11,000,000 and (ii) a five-year warrant to purchase 586,980 shares of our common stock at an exercise price of $12.00 per share, for total cash consideration to the Company of $10,000,000
|
•
|
On June 14, 2022, we issued 1,310,000 Common Shares pursuant to the Subscription Agreements entered into in connection with
the PIPE Subscription Financing for aggregate consideration of $13.1 million, plus 31,356 shares paid to certain investors pursuant to the convertible notes with such investors.
|
Item 16.
|
Exhibits.
|
|
| |
Description of Exhibit
|
| |
Amended and Restated Merger Agreement with Amendment No. 1 (included as
Annex A to the Proxy Statement/Prospectus filed with the SEC on May 17, 2022).
|
|
| |
Form of Certificate of Incorporation of SpringBig (incorporated by reference
to Annex B to the Proxy Statement / Prospectus of Tuatara filed with the SEC on May 17, 2022).
|
|
| |
Form of By-Laws of SpringBig (incorporated by reference to Annex C to the
Proxy Statement / Prospectus of Tuatara filed with the SEC on May 17, 2022).
|
|
| |
Senior Secured Original Issue Discount Convertible Promissory Note dated
June 14, 2022 between SpringBig Holdings, Inc. and the holder party thereto (incorporated by reference to Exhibit 4.1 to SpringBig’s Current Report on Form 8-K filed with the SEC on June 21, 2022).
|
|
| |
Common Stock Purchase Warrant SpringBig Holdings Inc. (incorporated by
reference to Exhibit 4.2 to SpringBig’s Current Report on Form 8-K filed with the SEC on June 21, 2022).
|
|
| |
Opinion of Benesch, Friedlander, Coplan & Aronoff.
|
|
| |
Form of Sponsor Escrow Agreement (incorporated by reference to Exhibit 10.1
to SpringBig’s Current Report on Form 8-K filed with the SEC on June 21, 2022).
|
|
| |
Amended and Restated Registration Rights Agreement, dated June 14, 2022, by
and among SpringBig, the Sponsor and other holders party thereto (incorporated by reference to Exhibit 10.2 to SpringBig’s Current Report on Form 8-K filed with the SEC on June 21, 2022).
|
|
| |
Form of Subscription Agreement (incorporated by reference to Exhibit 10.2 to
Tuatara Capital Acquisition Corporation Form 8-K filed on November 9, 2021).
|
|
| |
Securities Purchase Agreement, dated April 29, 2022, among Tuatara Capital
Acquisition Corporation, and the purchasers party thereto (incorporated by reference to Exhibit 10.1 to Tuatara’s Current Report on Form 8-K filed with the SEC on May 2, 2022).
|
|
| |
Registration Rights Agreement, dated June 14, 2022, among SpringBig Holdings,
Inc. and the investors party thereto (incorporated by reference to Exhibit 10.5 to SpringBig’s Current Report on Form 8-K filed with the SEC on June 21, 2022).
|
|
| |
SpringBig Holdings, Inc. 2022 Long-Term Incentive Plan (incorporated by
reference to Exhibit 10.6 to SpringBig’s Current Report on Form 8-K filed with the SEC on June 21, 2022).
|
|
| |
Executive Employment Agreement, dated November 8, 2021 by and between
SpringBig and Jeffrey Harris (incorporated by reference to Exhibit 10.7 to SpringBig’s Current Report on Form 8-K filed with the SEC on June 21, 2022).
|
|
| |
Executive Employment Agreement, dated November 8, 2021 by and between
SpringBig and Paul Sykes (incorporated by reference to Exhibit 10.8 to SpringBig’s Current Report on Form 8-K filed with the SEC on June 21, 2022).
|
|
| |
Common Stock Purchase Agreement, dated April 29, 2022, between Tuatara
Capital Acquisition Corporation and CF Principal Investments LLC (incorporated by reference to Exhibit 10.2 to SpringBig’s Current Report on Form 8-K filed with the SEC on May 2, 2022).
|
|
| |
Registration Rights Agreement, dated April 29, 2022, between Tuatara Capital
Acquisition Corporation and CF Principal Investments LLC (incorporated by reference to Exhibit 10.3 to SpringBig’s Current Report on Form 8-K filed with the SEC on May 2, 2022).
|
|
| |
Amendment No. 1 to Common Stock Purchase Agreement, dated July 20, 2022, by
and between SpringBig Holdings, Inc. and CF Principal Investments LLC.
|
|
| |
Letter from WithumSmith+Brown PC to the SEC, dated June 21, 2022
(incorporated by reference to Exhibit 16,1 to SpringBig’s Current Report on Form 8-K filed with the SEC on June 21, 2022).
|
|
| |
List of Subsidiaries of SpringBig Holdings, Inc.
|
|
| |
Consent of Marcum LLP, Independent Registered Public Accounting Firm of
SpringBig Holdings, Inc.
|
|
| |
Consent of WithumSmith+Brown, PC
|
|
| |
Consent of Benesch, Friedlander, Coplan & Aronoff (included in Exhibit
5.1)
|
|
| |
Power of Attorney (included on signature page)
|
|
101.INS
|
| |
Inline XBRL Instance Document
|
101.SCH
|
| |
Inline XBRL Taxonomy Extension Schema Document
|
101.CAL
|
| |
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
101.DEF
|
| |
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
|
| |
Description of Exhibit
|
101.LAB
|
| |
Inline XBRL Taxonomy Extension Label Linkbase Document
|
101.PRE
|
| |
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
104
|
| |
Cover Page Interactive Data File (formatted as Inline XBRL and contained in
Exhibit 101)
|
| |
Filing Fee Table
|
*
|
Filed herewith.
|
#
|
Indicates management contract or compensatory plan or arrangement.
|
†
|
Schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant hereby undertakes to furnish copies
of any of the omitted schedules upon request by the Securities and Exchange Commission
|
+
|
Previously filed.
|
Item 17.
|
Undertakings.
|
A.
|
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration
statement:
|
(i)
|
To include any prospectus required by section 10(a)(3) of the Securities Act;
|
(ii)
|
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most
recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in
volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of
prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee”
table in the effective registration statement.
|
(iii)
|
To include any material information with respect to the plan of distribution not previously disclosed in the registration
statement or any material change to such information in the registration statement;
|
B.
|
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be
deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
|
C.
|
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold
at the termination of the offering.
|
D.
|
That, for the purpose of determining liability under the Securities Act to any purchaser, each prospectus filed pursuant to
Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in
the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document
incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or
modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.
|
E.
|
That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial
distribution of the securities, that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the
securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:
|
(i)
|
Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant
to Rule 424;
|
(ii)
|
Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or
referred to by the undersigned registrant;
|
(iii)
|
The portion of any other free writing prospectus relating to the offering containing material information about the
undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and
|
(iv)
|
Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.
|
F.
|
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and
controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act
and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the
registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its
counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed
by the final adjudication of such issue.
|
|
| |
SPRINGBIG HOLDINGS, INC.
|
||||||
|
| |
|
||||||
|
| |
By:
|
| |
/s/ Jeffrey Harris
|
|||
|
| |
|
| |
Name:
|
| |
Jeffrey Harris
|
|
| |
|
| |
Title:
|
| |
Chief Executive Officer
|
Name
|
| |
Title
|
| |
Date
|
/s/ Jeffrey Harris
|
| |
Chief Executive Officer and Director
(principal executive officer)
|
| |
August 30, 2022
|
Jeffrey Harris
|
| |||||
|
| |
|
| |
|
/s/ Paul Sykes
|
| |
Chief Financial Officer
(principal financial officer and
principal accounting officer)
|
| |
August 30, 2022
|
Paul Sykes
|
| |||||
|
| |
|
| |
|
*
|
| |
Director
|
| |
August 30, 2022
|
Steven Bernstein
|
| |||||
|
| |
|
| |
|
*
|
| |
Director
|
| |
August 30, 2022
|
Patricia Glassford
|
| |||||
|
| |
|
| |
|
*
|
| |
Director
|
| |
August 30, 2022
|
Amanda Lannert
|
| |||||
|
| |
|
| |
|
*
|
| |
Director
|
| |
August 30, 2022
|
Phil Schwarz
|
| |||||
|
| |
|
| |
|
*
|
| |
Director
|
| |
August 30, 2022
|
Sergey Sherman
|
| |||||
|
| |
|
| |
|
*
|
| |
Director
|
| |
August 30, 2022
|
Jon Trauben
|
| |
|
|
| |
*By:
|
| |
/s/ Jeffrey Harris
|
|||
|
| |
|
| |
Name:
|
| |
Jeffrey Harris,
Attorney-in-fact
|